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ABSTRACT 
PART I 
Rabbit antibodies specifi c for the 3-(2-methyl-
piperidino)propyl-~-aminobenzoate group have been prepared 
and the i nhibition of precipitation of' these antibodies 
has been studied. It was found that a series of local 
anesthetics derived from piperidino alcohols were effective 
inhibitors of precipitation in t his sy stem. Reasonable 
explanations of the serological properties of these drug s 
have been given but it has not been found possible to es-
t ablish any relation between their serological properties 
and their pharmacological properties. 
PART II 
c14-carboxy~-labeled leucine has been administered to 
immunized rabbits. While receiving the labeled amino acid 
they also received intravenous injections of different 
antibody solutions. It was found that the normal con-
stituents of the serum incorporated the radioactivity at 
a very rapid rate but the passively transf erred antibodies 
either did not incorporate this radioactivity to any marked 
extent or else did so only upon the loss of their specific 
antibody charac t erist i cs. 
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PART I 
HAPTEN INHIBITION STUDIES 
WITH A SERIES OF LOCAL ANESTHETICS DERIVED FROM 
SUBSTITUTED PIPERIDINO ALCOHOLS. 
INTRODUCTION 
It has been known for many years that if an animal 
is given a series of injections of one of certain high 
molecular weight substances called antigens, which are 
usually protein in nature, there is produced in the serum 
of the animal certain modified proteins called antibodies 
which react visibly in vitro with the antigen used for im-
munization. Many investigators have explored the specifi-
city of the reactions and the properties of the substances 
involved (1) (2) (3). The introduction by Wu (4) of the 
methods of quantitative chemical analysis and their exten-
sive application by Heidelberger and Kendall (5) and others 
made possible a far more precise characterization of the 
various phenomena, particularly the precipitin reaction in 
which the soluble antigen forms a specific precipitate when 
added in suitable concentration to the serum of the immune 
animal. 
There are two different ways of performing a precipitin 
test. In one, varying amounts of antigen are added to a 
constant amount of antibody; in the other, the amount of 
antigen is kept constant and the amount of antibody is varied. 
A typical precipitin curve obtained with rabbit antibody 
performed by varying the amount of antigen shows a maximum 
in the amount of precipitate at some antigen concentration. 
At lower antigen concentrations there is not enough antigen 
to precipitate completely the antibody and at higher antigen 
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concentrations soluble complexes are formed with the ex-
cess antigen. If the concentration of antibody is varied 
an inhibition zone in excess antibody . can be demonstrated 
with horse antisera to proteins but horse antipolysaccharide 
and all rabbit systems do not normally give this effect. 
The qualitative features of the reactions of antibodies to 
simple substances. Interpretation of the precipitin re-
action in fundamental chemical terms was hampered by the 
fact that both reactants (the antigen and antibody) are 
macromolecular and of undetermined structure and the deter-
mination of the relative amounts of antigen and antibody 
in the precipitate has been difficult. The demonstration 
by Landsteiner and his collaborators that antibodies can 
be prepared with specificities directed against groups of 
known chemical structure - synthetic haptens - and that they 
react with simple synthetic substances whose molecules con-
tain the homologous or similar haptens (6) (7) (8) was a 
major advance in this field. Beginning in 1917 Landsteiner 
and his collaborators prepared artificially conjugated 
antigens by coupling relatively simple chemical substances 
to proteins (usually by diazotization), and then by in-
jecting these artificial antigens they prepared antibodies 
to them. The antisera produced were found to contain anti-
bodies capable of combining with the protein used in manu-
facturing the azoprotein and also antibodies with the spe-
cific power of combining with the attached group of known 
structure - the haptenic group. In preparing antibodies 
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against azoproteins they found that the antiserum not only 
has the power of forming a precipitate with the original 
azoprotein but also can form a precipitate with a different 
azoprotein containing the same or a very closely related 
haptenic group. A summary of the results obtained is given 
by Landsteiner (1). Of especial interest were the experiments 
by Landsteiner and Vander Scheer (9), in which they prepared 
antibodies directed against known peptides. These antibodies 
were found to be quite specific. Landsteiner and Van der 
Scheer have also differentiated serologically between ~ 
and ~-aminobenzoylphenylaminoacetic acid (10), and in other 
experiments between dextro, levo, and meso tartaric acid 
(11). 
Studies with these antibodies to s~ple chemical compounds 
were extended to include the combination with the simple sub-
stances themselves. It was found that for a simple substance 
to form a specific precipitate with antibody it is necessary 
that its molecule contain two or more baptens ( 8) (12). 
While all such polyhaptenic substances do not necessarily 
form prec i pitates, no monohaptenic substances do. However, 
this statement must be qualified because if a monohaptenic 
molecule bas a structure that favors the formation of 
polymers in saline solution, as among the larger azo dyes, 
precipitation with purified antibody is observed to occur -
the polymer is effectively polyhaptenic {13). In serum the 
polymerization equilibrium is shifted toward the monomer, 
since the concentration of free hapten in solution is greatly 
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reduced by its r eversible combination with serum albumi n 
and precipitation may not occur. 
Simpler monohap tenic substances do not form pr ecipi-
' 
tates even with purifi ed antibody (13). It has been demon-
strated however that monohap tenic subs tance s actually combine 
strongl y with antibody . Landsteiner s howed that the presence 
of monohaptenic substances specifically inhibits the pr eci -
pitation of antibody by polyhaptenic azoproteins (7 ) or 
simple substances (8). This phenomenon has been appl ied 
by Landsteiner and others (1) and by Pauling , Pressman , 
Campbell, et al . (12) i n extensive studies on specificity 
and its structural interpretation. Marrack and Smith (14) 
presented direct evidence for combination by e~ilibrium 
dialysis experiments. They f ound that when a hapten was 
dialysed against its specific anti body t he hapten accumul at ed 
in the antibody soluti on. Their r esults were confirmed by 
Haurowitz and Breinl (15). Lerman (16) has us ed the method 
of equilibrium dialysis i n an attemp t t o es timate the fr ee 
energy change of hapten combining with antibody and similar 
experiments have been reported by Eisen and Karus h (17) . 
The quantitative t heory of the reactions of antibodies to 
simple substances. Pauling a nd hi s coworkers have developed 
a quantitative theory f or t he precipitation of antibodies 
to simpl e substanc es a nd have extended this theory to cover 
hapten inhibition in these systems. An outline of their 
theory follows. Pauling et al. (18) considered an 
idealized antigen-antibody system in which the solution 
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contains antigen molecules A, antibody molecules B, soluble 
complex molecules A2B, and molecules AB in equili brium with 
a precipitate AB. They assumed that the two bonds in ABA 
are equal in strength and hence that the equilibrium con-
stants for the two reactions 
A +- B ~ AB 
differ only by the entropy factor 4, being 4K and /( re-
spectively. /( is the equilibrium constant for combination 
of a single haptenic group of an antigen molecule and a 
single complementar y region of an antibody molecule. They 
derived the equation 
#.8(/'.PJ = 4-r.d - ..5 - /7'..2:/~ra/- ~~r .. / -1" 
02-r-2 s 
L ..5(/?' /Y-5~ -r f4.r .. r..2Jr.Ta/J'Jij 
(I) 
in which #~?.f'J is the amount of precipitated compound, with 
solubility S , and A'~tda/ and 23~r'./ are the total amounts 
(per unit volume) of antigen and antibody in all molecular 
species, including the precipitate. 
The curves for the amount of precipitate, as a function 
of the amount of antigen, calculated with this equation 
{using arbitrary values for .I(' and s ) have the general shape 
indicated by the exper~ental points. 
This theory was extended to cover the phenomena of 
hapten inhibition. They considered a system containing in 
solution the molecular species H, BH, BH2 and ABH (H : hapten) 
as well as A, B, AB, and A2B and assumed the B-H bond 
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strength to be such that the equilibrium constants for 
the reactions 
B + H e::; BH BH + H 
and AB + H ===7 ABH 
were 2A('A(~ and ~respectively. / ~ is the equilibrium 
constant for combination of the hapten and the complementary 
region of the antibody . From these assumptions they derived 
the expressions 
r~) 
in which #r()t'c:i/ is the total hapten concentration. The 
other variables are &( , the concentration of the molecular 
species A in solution, and~, the concentration of the 
molecular species HB in solution. 
By combining these three equations they were able to 
show that at the equivalence zone where hJ:,n.; - 2r .. ~/ the 
amount of precipitate formed is a linear function of the 
hapten concentration and a relation of the form 
c c" 
- -+ 
../("" 
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where C== 
and c' = 
was derived. It was found however that the experimental 
points showing the dependence of the amount of precipitate 
on the amount of added hapten do not fall on a straight 
line except in the region of very low hapten concentration -
with larger amounts of hapten the inhibition is less than 
predicted by the above equation. Thi s deviation from 
linearity was attributed to the heterogeneity of the anti-
serum which appeared to contain antibodies of greatly 
varying combining powers. They extended the theory (19) 
to cover this by assuming that the heterogeneity of the 
antiserum was such that it could be described by a probabi-
lity distribution function which is an error function i n 
the effective free energy of combination of hap ten and 
antibody (in competition with antigen); that is, in the 
quantity ln (~:} , where /( 1is the effective hap ten i nhi-
bition constant of the particular antibody molecule under 
consideration and ~' is an average effective hapten 
inhibition constant . The normalized distribution function 
used was 
I 
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and the fractional number of antibody molecules with given 
value of ~1 in a differential region was 
-/~ f.--t'Jf;~~... ' 
L trd~f~;) 
They then assumed that for each kind of antibody the 
amount of precipitate is linear in the amount of hapten, 
with slope proportional to ~'and hence the amount of pre-
cipitate formed is given by the equation ~ ~~ ) ~( ~,1. :/ ? .: /?~t;PP) .:= /_ ~ ~/-/~' 
~..b"~p)L/ = 0 /77cJ _/ 
.-?".,.._""' / - C>.Q 
(/-_/r"~M) L -/.kf~)}A-d.&ef'1ii) 
I 
The upper limit of the integral represents the value of )( 
at which the hapten just inhibits completely the precipi-
tation of the corresponding antibody: no precipitate is 
formed by antibody with larger values of ~/ The integral 
was evaluated in terms of the Gaussian probability integral 
~('~) • The equation then assumed the form 
o:Xt. ?=;f(/~#td,J) - d-~M~ L ;)//r-.#~1 
where ~ = J~~~~) and ..Z-:2 -== ...Z/ - % 
This equation was used to plot ;u as a function of 
~ ~(~~/ for various values of ~ the heterogeneity in-
dex. The shape of such theoretical curves i s dependent only 
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upon the value chosen for 6 ; the effect of changing ~~ 
is simply to shift the curve along the ~ ~~/ axis. 
From the family of curves plotted the values of <)for ex-
perimental data can be obtained by fitting the experimental 
points to one of the theoretical curves. The positions of 
two curves along the 7 ~r.,/ axis can be used to 
evaluate the relative ~~. In a given antig en-antibody 
system the positions of the curves for two different hap-
tens can be measured by the amount of hapten giving fifty 
percent inhibition and the ratio of the two values gives 
the relative~~ The expression Llr= -,;f'~A{gives the 
difference in the standard free energies of combination 
with antibody. Usually a given hapten is selected as having 
I a~of unity and the other hapten inhibition constants are 
evaluated relative to this standard. 
Although Pauling and his coworkers have used the theory 
outlined to arrive at this method of evaluating the differ-
ences in free energ ies of combination of hapten and antibody 
they point out that 
"the evaluation and discussion of differences 
in the standard free energy of combination of 
different haptens with antibody is not depen-
dent on the assumption of any particular theories 
of the precipitation of antibody and antigen. We 
may consider that the precipitation with antig en 
is used as a method of fixing a standard concen-
tration of free antibody (for example, that which 
corresponds under the conditions of the experi-
ment to the formation of one-half as much precipi-
tate as is formed in the absence of hapten); the 
concentration of hapten necessary to reduce, by 
combination with part of the antibody, the concen-
tration of free antibody to the standard value 
is determined experimentally and the ratio of 
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concentrations for two haptens may then be in-
troduced in the well-known equation relating 
standard free energy change and equilibrium 
constant to give a value of the difference in 
the standard free energy of combination of the 
two haptens with antibody . The only assumption 
underlying our treatment of hapten inhibition 
data is that inhibition of precipitation is the 
result of combination of the antibody with 
molecules of hapten." (20). 
Steric effects in hapten inhibition experiments. It has 
been possible to interpret hapten inhibition data in terms 
of the structure of the haptens and the antibody combining 
site. The present concept of the antibody site is that it 
is a cavity on the surface of the protein into which the 
haptenic group fits. This concept has been used by Pauling 
and Pressman (20) in considering the effect of steric fac-
tors in hapten inhibition. Many of their studies were 
conducted with azophenylarsonic acids and drawing s were 
made of these groups using accepted bond distances and 
van der Waals radii. Circumferential contours, represent-
ing the antibody cavity in the plane of the benzene ring 
were drawn to fit the groups closely or with radial dilation 
of various amounts. Scale drawings of various substituted 
haptens were then superimposed on these drawings and the 
extent of dila t ion needed in order for ea ch hapten to fit 
was measured . Assuming that an increase in the required 
dilation corresponds to an increase in steric repulsion 
they were able to correlate this with a decrease in ...Yo" for 
diff erent substituted phenylarsonic acids. The substi-
tuents were in positions other than the position of the azo 
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linkage in the ~unizing hapten. 
The effects of changed electronic !!a ~ Waals interaction 
in hapten inhibition experiments. If a haptenic group has 
a substituent in the position of the azo linkage in the 
immunizing hapten there will be little steric effect to con-
sider. However the reaction of such haptene with antibody 
should be influenced by t he interaction of the substituent 
with the antibody. Pauling and Pressman (20) have also 
considered this possibility. London developed for the 
interaction energy of two groups or atoms the approximate 
expression 
.< /2. ~.8 (_z;p ... __za) 
in which ~ and a(8 are the electronic polarizabili ties of 
the two groups,~ and~ are average energy differences 
for the normal and excited states, and ~~8 is the distance 
between the gr oups. This expression was rewritten in the 
form 
._3S't:JO t:J 
/2~.8 
in which ,& and ~8 are the mole refrac tiona of the groups 
in cm3 < R=~O( ) and ..-z,A'4 is in Angstrom units. In re-
wri.ting this expression...l,; and .lir were taken as being 14 
electron volts which is an average for several molecules. 
The expression was then multiplied by a factor of 0.60 to 
give a 40% correction for the contribution of van der Waals 
repulsion. This equation has been applied in the calculat ion 
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of hapten inhibition constants for substituted haptens re-
lative to an unsubstituted hapten (containing a hydrogen 
atom rather than a substituent atom or group}. In applying 
the equation four energy quantities must be considered: 
the interaction of the substituent with antibody, the in-
teraction of the substituent with water, the interaction 
of the hydrogen atom with antibody, and the interaction 
of the hydrogen atom with water . The resultant difference 
in energy of reaction is 
LJ.a/ =- c:23:oo ( ,& - ~)(R#6-,e~kr) 
/Z ,98 
where~ andR~"'1~",..represent the ~ole refraction values in-
tegrated over the region of material in contact with the 
substituent group . ~ and ,.fN are the mole refrac tiona of 
the substituent and the hydrogen. For the studies that were 
being considered the region of material in contact with the 
substituent group was considered to be the volume of eight 
water molecules and so ,e~,..r was taken as 3" ~t' = 29 . 6cm3 
and from data on another protein A?~6 was estimated to be 
47.2 cm3 . The final expression derived can be written in 
the form ~t:)~ ~t? 0 ( ,e, - _RN) 
/Z. ,90 
or ~()t'J ()()0 ( ~ - .R.H) 
This expression was used to evaluate the relative 
inhibition constants and gave a rough quan titative agree-
ment with experiment when applied to a series of para 
substituted benzoic acids, phenylarsonic acids, and 
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)P -phenylazophenylarsonic acids. The marked deviations 
between calculated and observed effects could be satis-
factorily accounted for by hydrogen bonding. 
An electrostatic effect in hapten inhibition experiments. 
An interesting calculation has been made by Pressman et al. 
(a ) , who found tba t two hap tens which were identical except 
that one contained a N(CH3); group where the other had a 
C(CH3}3 group gave a ratio of 15.5 for their hapten inhi-
bition constants. This corresponds to a difference in 
standard free energy of combination with antibody of 1.5 
kcal. Identifying this free energy difference as Coulomb 
interaction energy between the N(CH3)j group and the 
antibody, they calculated that the positive charge of the 
0 .. hapten must be 7 Angstroms from a negative charge on the 
antibody. 
Some other factors in the precipitin reaction. An experi-
ment of fundamental importance to the theory of the 
precipitin reaction was the demonstration by Pauling et al. 
(22) that a simple substance containing two different 
haptenic groups gave only a slight prec i pitate with antisera 
to either of the two groups but when treated with a mixture 
of the two sera gave a relatively large amount of precipi-
tate. This precipitation could be inhibited by a mono-
haptenic substance of either type. This experiment is a 
strong support for the ttframework" theory of precipitation, 
which maintains that precipitation occurs as a result of the 
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~ormation of a large speci~ically formed aggregate of 
polyvalent antigen and at least divalent antibody. 
Exper~ents o~ the above nature have supported the 
present concept of antibodies as modified globulins that 
have portions of their surface complementary to the antigen 
causing their production. For a speci~ic reaction to occur 
between a substance and an antibody the substance must have 
structural ~eatures that enable it to fit the antibody site 
very closely. The forces responsible for antigen-antibody 
combination are presumably the forces of electronic van der 
Waals interaction, hydrogen bonding, coulombic attraction, 
etc., which are effective over short distances only (23), 
and hence closeness of ~it would be required for combination. 
This idea o~ complementary structures was first suggested 
by Breinl and Haurowitz (24), Alexander (25), and Mudd (26), 
and has come to be rather generally accepted. There is some 
intimation of it in the early work o~ Ehrlich and Bordet. 
The serological properties o~ simple substances ~hich have 
pharmacological properties. It has also long been recognized 
that chemical structure has a very important influence in 
drug activity (27), and some attempts have been made to use 
drugs as haptens in serological investigations. Many factors 
such as passage through membranes, diffusion, and trans~er 
from aqueous to lipoid phases must influence drug activity 
but it might be expected that molecular configuration would 
be an important factor in the reaction o~ a drug at its site 
of activity. The type of specificity involved mdght closely 
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resemble the specificity of an antibody for a haptenic 
group and if this were true substances with similar phar-
macological activity might be expected to have similar 
serological activity. 
Landsteiner (1) has summarized the earlier data on 
serological experiments with drugs. The earlier work was 
undertaken with the hope that non-antigenic poisons after 
combination with protein might produce antibodies capable 
of neutralizing their toxic effect. This possibility was 
tested by Berger and Erlenmeyer (1) with an antiserum to 
dimethyl-N-pyrrol-phenylarsenic acid, but the results were 
negative. Stokinger and Heidelberger (28) produced anti-
bodies to thyroglobulin and confirmed the fact that the 
antitbyroglobulin-thyroglobulin precipitation was not inhi-
bited by thyroxine or diiodotyrosine. Hooker and Boyd (29) 
were unsuccessful in attempts to prepare antimorphine serum 
but were able to produce antibodies specific for strychnine 
in rabbits by injections of monoaminostrychnineazohemocyanin. 
The sera they obtained were very low in antibody and failed 
to neutralize the lethal effect of strychnine in mice. They 
also carried out precipitation tests with these antisera 
and a caseinazostrychnine antigen and found that the preci-
pitation could be inhibited by the presence of the alkaloid 
and also by s.ome of its amino 1 nitro, and metho.xyl 
derivatives, but not by the presence of morphine, quinine, 
tryptophane, or nicotinic acid. Glutton, Harington, and 
Yuill (30) prepared thyroxyl derivatives of horse serum 
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globulin and albumin. These substances and thyroglobulin 
caused the production of antibodies specific t o the whole 
aromati c portion of the thyroxine molecule. Passive i mmuni-
zation with these antisera to thyroxylproteins protected 
rats against the normal physiological effects of exogenously 
administered thyroglobulin and thyroxine. The authors 
thought that the neutralizati on of thyroxi ne could be in-
direct inasmuch as thyroxine may exert its activity after 
having been conver ted to thyroglobulin . Butler, Haring ton, 
and Yuill (31 ) studied the immunological properties of aspirin. 
These workers prepared aspiryl-protein complexes by coupling 
acetylsalicylazide with horse and rabbit serum globulins. 
Immunization of rabbits with aspiryl horse serum globulin 
gave anti.sera specific to the aspirylamido grouping . Such 
sera were able partly to protect rats, suffering from pyrexia 
as the result of injection of y east, from the normal 
anti pyretic effect of aspirin. They a lso found that the 
precipitation reaction between this serum and aspiryl rabbit 
serum globulin could be inhibited with aspiryl - or 
salicylglycine but aspirin and salicylic acid were relatively 
inef fective as inhibitors of precipitation. Wedum (32) in-
vestigated the cross reactions of the sulfonamides with 
antisera produced in rabbits and humans. Cohen and Friedman 
(33) claim to have succeeded in neutralizing in vitro t he 
physiological effect of small amounts of histamine with the 
serum of patients treated with histamineazoprotein. However, 
Coffin and Kabat (34) have reported that the treatment of 
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guinea pigs with histamine-azoprote i n confers no protection 
against histamine. Allergic reactions to drugs in humans 
have been studied in many clinical investigations (35). 
Perhaps the most extensive series of immunochemical 
investigations with drug-protein antigens are those of 
Went, Kesztylis, and their coworkers (36-46). In their 
earlier work they too found that immunization with thyro-
globulin produced antiserum which was capable of !~biting 
the effect of thyroxine in rats and guinea pigs (36). Later 
they used adrenaline azoprotein to produce what they believed 
to be a specific adrenaline immune serum in rabbits (37) 
and found that this antiserum did not affect adrenaline 
activity in rats and frogs although rats immunized with 
adrenalylazoprotein did not show the same respiratory effect 
as normal rats upon the administration of adrenaline (39) 
(40). Of course, in these experiments that involve the 
protection of an animal actively immunized with a drug-protein 
complex a consideration must be given to the possibility of 
the animal developing a tolerance to the drug by some means 
not associated with serum antibody formation. This group 
of workers have also prepared histamine antibodies (41) 
(42) (43) by using an antigen prepared by diazotizing 
~-aminobenzeneazohistamine to horse or cattle serum. They 
state that precipitation reactions were not affected by 
horse or beef protein (42). Inhibition of precipitation of 
the histamineazoprotein system could be obtained with aniline, 
J-aminobenzeneazohistamine, and histamine, but naphthol or 
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phenol had no effect. Went and Kesztyus (44) also have 
investigated the production of antibodies to novocaine. 
Novocaine hydrochloride was diazotized and coupled with 
ca·ctle or horse serum and the novocaine azo cattle serum 
was used to produce rabbit antibodies. Such antiserums 
gave precipitation reactions with novocaine azo cattle 
serum a nd novocaine azo horse serum but did not react with 
the proteins of natural cattle serum or natural horse serum. 
In precipitation inhibition tests, novocaine, larocaine, 
and anesthesine hindered the precipitation of novocaine 
azoprotein antibodies whereas orthoform (~-wmino­
P-hydroxy-methylbenzoate), aniline, )D-aminobenzoic acid, 
)D- aminobenzenesulfonamide, and cocaine had no effect on 
the reaction. The authors believed their experiments showed 
a possible dependence of group specificity on the amino 
group of the benzene ring in the para position to an 
esterified carboxyl group. This same group in later reports 
rediscussed the above results (45) (46) and concluded that 
their inhibition tests indicated that there was at least a 
partial speci~icity to local anesthetics that were deriva-
tives of p-aminobenzoic acid. This serum when mixed with 
procaine (novocaine) inhibited the papulous eruption in an 
allergic patient. 
The studies with local anesthetic drugs are especially 
interesting as it is known that these compounds are capable 
of blocking nerve conduction when applied locally to nerve 
tissue in effective concentrations (47). Although the 
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problem of nerve conduction is still in a state of contro-
versy (48-54), it appears that acetylcholine plays a very im-
portant part in this phenomenon and it is possible that local 
anesthetics acting on nerve surfaces and a t the junctions 
of nerve with muscle may interfere with the action of 
acetylcholine. However, in the light of existing knowledge 
there is no way of connecting the action of these drugs with 
t he chemistry of choline and its metabolic associates. 
Object of this research. A large number of benzoates and 
substituted benzoates have been synthesized and tested for 
anesthetic action and practically no general rules can be 
applied for predicti ng the change of activity resulting from 
a change in structure (55). Nevertheless, it was thought 
that the serological investigation of such a series of local 
anesthetics might yield some interesting data which could 
possibly be correlated with anesthetic activity. Eli Lilly 
and co. prepared a series of compounds derived from sub-
stituted piperidino alcohols which have been investigated 
for toxicity and local anesthetic properties (56). Some 
of these compounds were made available for the studies dis-
cussed in this thesis. 
The object of this work was to obtain antibodies spe-
cific to one of this series of drugs and to study the inhi-
bition of the precipitation reaction by its analogs. In 
order t o avoid any specific reactions due to the antigenicity 
of the protein used in the immunization, a different protein 
was selected to make the antigen used in the precipitation 
tests. 
-20-
EXPERIMENTAL 
Preparation of antigens. One of the compounds investigated 
in this series was 3-(2-methylpiperidino)propylbenzoate 
hydrochloride and this compound was modifi ed by Eli Lilly 
and Co. to include an amino group in the pa r a position of 
the benzene ring. The amino group made it possible to 
diazotize this compound onto proteins. The rirst attemp t s 
to produce antibodies to this drug were made with an antigen 
pr epared by coupling the drug to bovine globulin. In the 
f i rst preparation 11 g of bovine globulin (Armour and Co. 
Fractions II and III) were shaken overnight in 150 ml of 
distill ed water; about half of the material dissolved, and 
the remainder was centrifuged out of the solution. The 
superna tan t was cooled to 0°C. A solution of 0.417 g of 
3-(2-metbylpiperidino)propyl-p-aminobenzoate hydrochloride 
(L-1) in 8 ml of 0.5 N hydrochloric acid was prepared and 
cooled to 0°C. An ice-cold solution of 0.096 g of sodium 
nitrite in a rew ml of distilled water was prepared. The 
ice-cold nitrite solution and L-1 solution were mixed and 
allowed to s tand ror 20 minutes in an ice-salt bath . The 
solution was checked f or exces s nitrous acid with s t arch-
iodide pape r and the excess n i trous acid was removed with 
a little sulfamic acid. This solution was then slowly 
added wi th stirring to t he ice-cold protein solution and 
1 N sodium hydroxi de was periodically added to k eep the 
s oluti on at;>H 9.0. A larg e amount of a red precipitate 
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formed, which would not redissolve. The mixture was 
dialyzed against water for 48 hours and was then shaken 
overnight with enough sodium chloride to give a 1% sodium 
chloride solution. The precipitate which still remained 
was removed by centrifugation. The original mixture cor-
responded to about 40 hapten groups per protein molecule, 
but possibly the material remaining in solution was the 
protein with the smaller numbers of diazotized groups. The 
final solution contained only about 1% protein. 
In a similar manner the drug L-1 was coupled to rabbit 
serum albumin and also to human serum albumin. These 
azoproteins also proved to be relatively insoluble. Further 
preparations of the L-1-bovine globulin antigen (L-lBG) were 
made using different ratios of drug to protein but in all 
cases a large fraction of the material produced was in-
soluble. 
Preparation of antisera and preliminary tests. Over a period 
of a year a large number of rabbits were injected biweekly 
with 1 ml portions of the L-lBG antigen but only a few pro-
duced measurable quantities of precipitating antibodies. 
The positive sera were pooled and the pooled material gave 
about 0.3 mg of precipitate per ml when titrated with the 
L-lHA (L-1-human serum albumin) antigen. In spite of this 
low titer a preliminary set of experiments were carried 
out to see if any inhibition of precipitation could be ob-
tained. 
Solutions of the various drugs were made up containing 
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6 mg of drug per ml in saline solution. One ml of drug 
solution was placed in each of three tubes and to each tube 
1 ml of the pooled serum was added and the mixtures were 
allowed to stand at room temperature for thirty minutes. 
To one tube 1 ml of a 1/10 dilution of the L-lHA antigen 
was added, to another 1 ml of a 3/100 dilution of the L-lHA 
was added, and to the third 1 ml of a 1/100 dilution of the 
L-lHA was added. This corresponded to 1.3 mg, 0.39 mg, and 
0.13 mg , of L-lHA respectively. These mixtures were allowed 
to stand at room temperature for two hours and were then 
stored in a refrigerator for three days. Identical tests 
were performed with seventeen of the drugs. A control test 
was performed using l ml of' saline instead of the drug solu-
tion. The precipitates were all washed twice with ice-cold 
saline, removing the precipitate each time by centrifuging 
for 30 minutes at 3000 rpm in an International refrigerated 
centrifuge keeping the temperature near 4°C. The amounts 
of precipitate in the tubes were measured by nitrogen 
determinations using the Nessler method. The colorimetric 
readings were made with a Klett colorimeter. The results 
are shown in Table 1. As this experiment indicated that 
inhibition did occur attempts were continued to produce a 
better antiserum. It is to be noted that no attempt was 
made to buffer the precipitation tests so this experiment 
has only qualitative significance. 
In an attempt to produce a higher titer antiserum 
several rabbits were injected with the insoluble L-lBG 
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material. The material was suspended i n saline and steri-
lized by repeatedly heati ng it at 56°c. ror halr hour 
periods. This was then administered to the rabbits by 
intraperitoneal injections . Biweekly injections were g iven 
over a ten week period but the rabbits failed to show any 
antibodies specific to the immunizing hapten (L-1). Ten 
rabbits were g iven injections of the soluble fraction of 
the L-lHA antigen. These rabbits also failed to produce 
s i gni ficant antibody titers. Finally some fresh sheep serum 
was obtained and the drug L-1 was diazotized to this whole 
serum. Enough L-1 was used to give about 40 hapten groups 
per average protein molecule and the coupling was carri ed 
out in the same manner as before. It was noted that the 
solubility or this material was quite sensitive to p H. In 
general the antigens were kept at about J> H 8 and at this 
point the L-lSS (L-1-sheep serum) was only partially soluble. 
However, if the material was adjusted to y H 10 it was 
practically completely soluble. Some of this materi al at 
p H 10 was injected intravenously into some rabbits and 
the high J> H did not seem to affect them adver sely. Con-
sequently the antigen was stored at -p H 8 and small quanti -
ties were taken periodically, adjusted to F H 10, and used 
for immunization. The rabbits were given biweekly injections 
of l ml each. The results were the most favorable obtained: 
after ten weeks of injections some of the animals gave 
serums which yielded a little less than l mg of prec i pitate 
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per ml when titrated with the L-lHA or the L-lBG antigen. 
Thes e animals were injected for over a year with the L-lSS 
material, and continually yielded sera giving from 1/3 to 
1 mg of precipitate per ml when titrated with a heterologous 
antigen. The sera obtained were pooled and the mixture was 
passed through Seitz filters and stored in sterile bottles. 
Different pools of this anti L-lSS serum were used for all 
the later experiments. 
Hapten inhibition studies. As sufficient serum was avail-
able it was thought that it might be interesting to run 
parallel experiments with the antibody containing globulin 
fraction of the serum. A portion of the serum was one-third 
saturated with ammonium sulfate and the mixture adjusted to 
? H 7.8 and allow~d to stand for one hour at room temperature. 
The precipitate wa s centrifuged out and dissolved in saline, 
the final volume being about half the original volume of 
serum. The precipitation was carried out twice more and 
the final solution was dialysed for two days against cold 
saline. The final solution was diluted with saline to give 
an antibody concentration similar to that in the original 
serum. 
For these experiments the drugs were dissolved in 
borate buffer at? H 8.0. Solutions 1.5 x 10-2, 1.5 x lo-3, 
1.5 x lo-4, 1.5 x lo-5, and 1.5 x lo-6 molal in drug were 
made . The antigen dilution required for maximum precipi-
tation in the absence of any hapten was also made up in the 
)D H 8.0 borate buffer and this was used in the hapten 
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inhibition tests. All the precipitations were made in the 
following manner. One ml of the antibody solution was mixed 
with 1 ml of the drug dilution and the mixture wa s incubated 
at 37°C. for half an hour. One ml of the antigen dilution 
(L-lBG) was then added and the mixture wa s incubated for 
another hour at 37°C. The mixture was placed in the re-
frigerator for 48 hours and the precipitate was treated in 
the same manner as described previously. In all the experi-
ments using buffer as a diluent the pooled supernatants from 
the precipitations varied in ?H from 7.9 to 8.1. This 
method of performing the inhibition tests is essentially the 
same as used in the work of Pauling, Pressman, Campbell et 
al. (12). The results of the final experiments are g iven 
in Table II and Figures I,II, and III. These tes ~s were 
all carried out in triplicate. Earlier tests performed only 
in duplicate gave essentially the same results. As can be 
seen, the whole serum and the globulin fraction gave very 
similar results. 
In a further experiment all the drugs were used in a 
1.5 x lo-2 molal solution and also a number of related simple 
compounds were used as inhibitors. The simple compounds 
were all used as 1.5 x lo-2 molal solutions in· borate buffer 
at )DH 8.0. One ml of these solutions were used in the 
precipitation tests, which were carried out in the same 
manner as before. The experimental data are given in Table 
III. The molecular formula of each drug and simple compound 
is given in Table IV. The data on the toxicity and anesthetic 
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properties of the local anesthetics as determined by McElvain 
and Carney (56) are given in Tables V and VI. 
DISCUSSION 
Hapten inhibition constants. One of the controlling factors 
in these experiments was the limited solubility of some of 
the drugs being investigated. In the first experiment there 
was some indication that some of the drugs were tending to 
come out of solution at 4°c. This was especially true of 
drug L-201, and as this would have a serious effect upon the 
results it was decided that the most concentrated solution 
of all the drugs that should be used was 1.5 x lo-2 molal. 
This limited the data available for the curves shown in Fi gures 
I, II, and III, which represent the results obtained from 
the experiments in which the concentration of hapten was varied. 
In some cases the amount of precipitate obtained with this 
maximum drug concentration was still more than half that ob-
tained when no drug was present. However, the curves ob-
tained all show a similar shape, corresponding to a 
heterogeneity index of five, and by fitting the theoretical 
curve corresponding to this value to the experimental points 
t he concentrations of the drugs required for fifty-percent 
inhibition were evaluated. The ratio of the concentration 
obtained for drug L-1 to the concentration obtained for each 
of the other drugs was determined and this gave the hapten 
inhibition constant relative to that of L-1 as unity. For 
example, from the data of Figure I the concentration of L-1 
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producing 50% inhibition was estimated as lo-2·55 and the 
concentration of L-134 producing 50% inhibition was esti-
mated as lo-2.05. This gives as the ratio of the concen-
trations lo-2·55/lo-2• 05 = l/10 0.50 = 0.32. This figure, 
0.32, is the hapten inhibition constant()(~) for L-134· 
In a similar manner the values for the other drugs were ob-
tained. In the second series it was again assumed that the 
curves are all of the same shape, and the inhibition con-
stants were again evaluated relative to that of L-1. 
In the first series the concentrations of the various 
drugs required for fifty-percent inhibition vary by not 
more than a factor of 5.3. (The extreme values are lo-2•72 
for L-208 and 10-2.00 for L-161.) This corresponds to a 
difference in the free energy of the reactions of the drugs 
with antibody of 2.303 RT log5.3 =920 calories per mole. 
The drugs are all very similar in their effect as inhibitors 
of precipitation in the system studied. It is to be noted 
that t he relative inhibition constants vary somewhat in the 
two series. The serum used in the second series was a pool 
from the same rabbits but taken after a further series of 
injections. 
As stated earlier, the data obtained with the globulin 
fraction of the serum were quite similar to those obtained 
with whole serum (Table II-H), and thus it can be concluded 
that these drugs interact only slightly with rabbit serum 
albumin. 
The structur~of the various drugs .used as inhibitors 
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of precipitation are given in Table IV. The basic struc-
ture of the drugs is that of drug L 
CH3 
I 
0 CH- CH2 
c~ I \ 
OCH2CF 2c• 2-N\ /C~ 
C~-C~ 
It is quite difficult to correlate the inhibitory pro-
" perties or the drugs with their structures, especially 
considering how little variation in inhibition was shown. 
However the erfects of various modirications or the basic 
structure are discussed below. 
The effect of additional methyl groups ££the piperidine 
~· It might be expected from the manner in which the 
drug L-1 was coupled to the carrier protein that substituents 
on the piperidine ring would be most significant in altering 
the closeness of fit of the antibody and hapten. Some of 
the drugs contain additional methyl groups on the piperidine 
ring and they do decrease the interaction of the drug with 
antibody . 
The two drugs L-135 and L-136, which differ in that 
L-136 has a methyl substituent in the six position of the 
piperidine ring, gave as the ratio or their hapten inhibition 
constants 1.49 in the second series and 1.52 in the rirst 
series. If 1.50 is taken as the average of these results a 
difference in free energy of combination with antibody of 
2.303 RT log 1.5 or about 220 calories is obtained. This 
difference is due presumably to the steric effect of the 
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second methyl group. 
The drugs L-172 and L-161 also differ by a methyl group 
in the six position of the piperidine ring, and in this case 
the free energy difference is about 280 calories, although 
the agreement between the values in the two series is not 
as good as in the previous example. It may be concluded 
that the introduction of the methyl group into the six 
position decreases the free energy of the reaction by about 
250 calories. 
If only the values obtained in the second series are 
considered it is calculated that the effect of a methyl 
group in the six position is to decrease the free energy of 
combination by 160 calories (L-172, L-161), and the effect 
of a methyl group in the four position is to decrease the 
free energy by 370 calories (L-172 and L-206, which is the 
same as L-172 except for a methyl group in the four position 
of the piperidine ring). The effect of introducing methyl 
groups in both the four a~d six positions is to decrease the 
free energy by about 470 calories (L-172, L-aD7), which is 
reasonably close to the sum (530 calories) of the individual 
effects. 
The effect of a methyl group in the three position is 
uncertain, as in the first series it decreases the free energy 
by 210 calories and in the second series increases it by 
about 41 calories (L-172 and L-205) . 
It may be concluded that the methyl group in the four 
position is the most effective in decreasing the interaction 
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of drug and antibody. A methyl substituent in the three 
position bas the least e£fect, probably decreasing the in-
teraction slightly, and a methyl group in the six position 
has an intermediate effect. 
It is interesting to interpret these effects in terms 
of the radial dilation required o£ the antibody site in order 
for the hapten to fit into the site. Drawings were made of 
the 2-metbylpiperidine group with use of the accepted bond 
distances and van der Waals radii (57), and circumferential 
contours, representing the required antibody cavi~ were 
drawn to fit the group closely or with radial dilation of 
0 0 0 0.5 A., 1.0 A., and 1.5 A. The following figure shows the 
outline of this group in the plane of the four central carbon 
atoms of the ring. The methyl substituent was taken in the 
position which places the ring to methyl group bond nearly in 
this plane in order to give the largest area in this plane. 
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The second figure shows the outline of the gr oup in a 
plane perpendicular to the plane of the four central carbon 
atoms. In this case the methyl substituent was taken in the 
position which places the ring to methyl group bond almost 
parallel to this plane in order to give the larges t area in 
this plane. The dashed contours in this figure represent 
the circumrerential contours in a plane behind the drawing. 
(The six position has no methyl substituent as in the two 
position). The 'chair' f orm of the r ing was used in these 
drawings but the 'boat' f orm could be used without altering 
the discussion. 
/ 
--- / ,.... / _..,.,. / 
,..--- , __ .,..., 
......--
' 
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Scale drawings of the other me thyl substituted piperi-
dine ring s were superimposed on these drawings keeping the 
ni t r ogen of the ring in the same position and retaining the 
same orientation for the ring . IJ:'he extent of dilation needed 
• 
for each hapten wa s dete rmined in both planes. It is obvious 
from the first figure t ha t a methyl group in the four position 
would require a dilation of a bout 1.5 ~. (Approximately equal 
to the C-C bond distance of 1.54 ~.) , Methyl group s in the 
three and six positions require almost the same dilation, the 
values being 1.3 ~. and 1.4 ~. respectively. I n the second 
figure it is seen tba t the methyl group in the four position 
again requires a dilation of 1.5 ~. i f t he bond is parallel 
to t he plane of the four central carbon atoms and a dilation 
of 1.3 ~. if it is in the other position. A methyl group in 
the three position requires a maximum dilation in this p lane 
of a bout 1.3 R. A methyl gr oup in the six position, which is 
behind t he plane of the figure, would require a di l a tion in 
this plane of about 1.5 ~. 
From these considerations it would be pr e dicted that a 
methyl group in the f our position would have the grea test 
effect in reducing t he interaction with antibody and a methyl 
group in the six position s hould have almost as great an 
effect. The methyl substituent in t h e three position should 
have the least effect. Qualita tively the experimental data 
s upport this. However t he effects of a me t hyl group in the 
f our position and a methyl group i n the six position do not 
seem to be as close as required and this may be because the 
methyl group in the six position is closer to the entrance 
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of the site where dila t ion may occur more readily . It is 
perhap s surprising that a methyl group in the three position 
has such a small eff ec t and this may be a reflection of a 
general poorness of fit of these antibodies •. 
The effect of additional methylene groups. Several of the 
drug s are modified to include one or more methylene groups 
adjacent to the carboxyl group. L-134 is an example of this 
series 
These modifications decrease the inhibitory power of the 
drugs and this can perhaps ce explained on the basis of a 
decreased interaction between the antibody and the second 
ring structure. 
The high heterogeneity index of this series of haptens 
(5) presumably results from an abnormally great variability 
of strength of attraction of antibody and azoprotein antigen 
or hapten. This may be account ed for by the possible varia-
I 
tion in configuration of the drug s about the propyl group. 
Most of the quantitative studies of hap ten inhibition have 
been conducted with haptenic groups of rather rigid struc-
ture, whereas in the compounds used in this study a gr eater 
variation in configuration is possible; this may explain 
the relatively ,poor antigenicity and high heterogeneity 
in this system. The introduction of further methylene 
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groups probably increases the variability in structure and 
consequently decreases the interacti on between hapten and 
antibody. This effect is shown by drugs L-134 (~~0.41), 
L-137 ~~0.28 ), L-170 (~:0.45 ), L-202 (~~0.45), and 
L-203 (~~0.41) in the second series. In the first series 
L-170 gave a rather high value ~~0. 89 ) but the others 
tested were low in this series too. L-17~which contains 
an ethyl substituted methylene group in this position, does 
I 
not show the effect to such a marked extent (A;)'= 0. 72) and 
this may be accounted for by interaction of the ethyl group 
The structure of L-134 is given above. 
Drug L-1711 gave hapten inhibition constants of 0.72 
and 0.79 while drug L-134, which is identical with it excep t 
f or the e thyl subs t ituent, gave inhibi tion constants of 0.41 
and 0. 32. It may be concluded that the inhibition constant 
of L-171 relative to that of L-134 is a bout 2.1 (1.76/0.37). 
This~/ (relative toA;;~l for L-134) has a logari t .hm of 0.31. 
I f the express i on 
log ~'= 400,000 (RA - RH) 
2.303 RT r~b 
developed by Pauling and Pressman (20) is applied to this 
case the value calcula ted f or log~ls about 0.71. In 
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making this calculation a difference of mole refraction for 
the ethyl group and the hydrogen of 9.2 cm3 was used. The 
distance between the groups (rab) was taken as the minimum 
distance of separation, 4.0 ~. As might be expected from 
the large value of the heterogeneity index, the value cal-
culated is greater than the experimental value. If it is 
assumed that the separation is somewhat greater than this 
minimum distance and a value of 4.6 X. is used a theoretical 
value in agreement with the experimental one is obtained. 
The effect of other modifications in the structure of ~ 
drugs. Although some of the drugs contain substituted ben-
zene rings as the second ring structure it is not possible 
to evaluate the effect of various substituents from the pre-
sent data. L-204 and L-205 differ in that L-205 contains 
an ortho hydroxyl group; 
This compound gave a~~ of 0.72, as compared to 0.89 for 
L-204. L-134 and L-202 differ by a para hydroxyl group in 
L-202; they have almost the same inhibition constant (0.41 
and 0.45 respectively). In the series L-1, L-172, L-173, 
the values of the inhibition constants are 1.00, 0.67, and 
0.81, corresponding to a para amino, an ortho hydroxyl, and 
an ortho benzoyl substituent respectively. The only marked 
effect is the low value of 0.14 for L-201, which contains a 
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para benzoxy group. This is parallel to the difference be-
tween L-134 and L-137 in the second series. L-137, which 
contains a para methoxy group, bas a constant of 0.28 as 
compared with the value 0.41 for L-134· However, in the 
first aeries the effect was reversed, the values being 0.50 
for L-137 and 0.32 for L-134. L-170, which is similar to 
L-134 except that the second ring is cyclohexane rather than 
benzene, gave values of 0.45 in the second series and 0.89 
in the first series. 
Some of the drugs contain different cyclic structures 
for the second ring but again not enough different structures 
are available to investigate their effect. The most notable 
feature is the high value (1.47 and 1.12) for the inhibition 
constant of L-208, which has the structure 
Inbibition 2£ precipitation £l other simple compounds. The 
effect of certain simple compounds upon the precipitation in 
the system studied is given in Table III. The simple com-
pounds used are listed at the end of Table rv. Of the simple 
compounds tested only triethylamine and tri-n-butylamine 
seem to have any significant inhibitory action. Trimethyl-
amine, acetylcholine chloride, choline chloride, and the 
secondary and primary amines tested caused very little or 
practically no inhibition of precipitation. Propionic acid 
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had no effect and benzoic aci d bad only a small effect at 
the concentration used. 
The above results would seem t o indicate that a tertiary 
nitrogen atom is required for interaction with the antibodies 
t o drug L-1. The failure of trimethylamine to show a signi-
ficant effect may be due to the methyl groups being not 
quite large enoug h. The related structure in t he drugs is 
the propylpiperidine group. 
The relation of the hapten inhibition data t o the pharmaco-
logical data. A comparison of the hapten inhibition activity 
with the local anesthetic action is g iven in Table VII; it 
can be seen that no obvious correlation exists. However, 
as the inhibition experiments were performed with solutions 
of equal molality and the pharmacological data were obtained 
with one percent solutions a further comparison was made 
with the drug s in groups of like molecular weight. This 
comparison is given in Table VIII. Again no correlation 
has been observed between anesthetic action, toxicity , and 
hapten inhibition properties. It was thought that some 
slight correlation may have existed between the data of Table 
I and the local anesthetic action of the drugs, with the 
poorer anesthetics giving less inhibition of precipitation. 
However, there is no general overall correlation, and there 
are exceptions to the trend. Considering the small amounts 
of precipitate and the manner in which these tests were per-
formed this cannot be regarded as significant. 
In conclusion it may be stated that the discussion of 
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these exper~ents has provided reasonable explanations of 
the serological properties of these drugs, but that it bas 
not been found possible to establish any relation between 
their serological properties and their pharmacological pro-
perties . 
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TABLE I 
Hapten Inhibition Experiment with Antiserum to 
L-lBG Using L- lHA as the Precipitating Antigen. 
Protein Precipitate in Milligrams 
Antigen 
Dilution 1 : 10 3 : 100 1 : 100 
Saline 0. 136 0 . 288 0. 277 
Drug 
L- 134 . 096 . 198 . 183 
L-137 . 072 . 172 . 167 
L- 201 . 102 . 165 . 212 
L-203 . 049 . 162 
·143 
L-136 . 072 . 156 . 186 
L- 170 . 056 . 156 . 145 
L- 202 . 059 . 154 . 158 
L- 204 . 038 . 121 .135 
L- 135 . 040 . 120 . 114 
L- 173 . 038 . 110 . 102 
L- 208 . 019 . 102 . 116 
L- 171 . 046 . 091 . 111 
L- 161 . 027 . 076 . 089 
L- 205 .016 . 057 . 070 
L- 206 . 027 . 046 . 076 
L- 172 . 035 . 029 . 049 
L-1 . 035 . 032 . 027 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
A. Whole Serum 
Average 
Drug Dilution Klett Readings Average -Blank 
L-171 1.Sx1o- 2 174 171 172 172 96 
1.sx1o-a 211 216 214 214 138 
1 . 5x1o-
5 259 
262 262 261 18.5 
1 . 5x1o-6 279 277 279 27 8 202 1 . 5x10- 268 275 279 274 198 
L- 208 1 . 5x1o- 2 157 160 1.58 158 82 
1 . 5x1o-3 200 206 206 204 128 1. 5xlo-~ 262 268 271 267 191 
1.5x1o-6 276 270 275 274 198 lo5xlo- 265 275 273 271 195 
L- 173 1 . Sx1o-2 168 165 166 166 90 
l . Sxlo-, 212 211 211 211 135 
1 • .5xlo-
5 
263 262 269 26.5 189 
1 • .5x1o- 6 269 273 271 271 19.5 1 . 5xlo- 269 27.5 271 272 196 
Saline Control 278 278 274 277 201 
~;.Ratio : - Ratio of amount of precipitate t o amount of 
precipitate obtained in saline control (no 
inhibitor present) 
Ratioit-
0.48 
o69 
. 92 
1.00 
0.99 
·tl 
• 4 
.95 
.99 
. 97 
· ~5 
• 7 
.94 
.97 
. 98 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
B. Whole Se~um 
Average 
Drug Dilution Klett Readings Average - Blank 
L-134 1.5xlo-~ 192 192 195 193 114 
1.5xlo-
4 
230 229 229 150 
1.5xlo-
5 264 
265 272 267 188 
1.5xlo-6 282 273 274 276 197 1.5xlo- 276 279 281 279 200 
L-170 1.5xlo-2 168 174 171 171 92 1.5xlo-~ 211 215 215 214 135 
1.5xlo- 258 271 262 264 185 1.5xlo-~ 268 272 273 271 192 
1.5x1o- 264 272 265 267 188 
L-137 1.5xlo-2 175 176 177 176 97 
1.5x1o-, 229 233 234 232 153 
1.5xlo-
5 
268 266 267 267 188 
1.5x1o- 276 274 279 276 197 
1.5xlo-6 274 282 274 277 198 
Saline Control 276 274 275 275 196 
*Ratio:- Ratio of amount of precipitate to amount of 
precipitate obtai ned in saline control(no 
inhibitor present) 
Rati~ 
0.58 
-77 
.96 
1.00 
1.02 
0.~7 
• 9 
-9~ 
.9 
.96 
. 50 
.78 
.96 
1.00 
1.01 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
c. Whole Serum 
Average 
Drug Dilution Klett Readings Average - Blank 
L-135 1.5x1o·2 165 162 164 164 87 
1.5xlo-3 209 212 210 210 133 1.5xlO-~ 259 255 256 257 180 
1.5xlo-6 271 271 266 269 192 1.5x1o· 268 273 267 269 192 
L-205 1.5x1o-2 181 181 184 182 105 
1.5xlo-3 227 225 223 225 i~ 1.5xlo-~ 260 260 264 261 
1.5x1o- 263 265 264 187 
1.5xlo-6 268 273 273 271 194 
L-1 1.5xlo-2 167 165 170 167 90 1.5xlo-~ 197 193 194 195 118 
1.5xlo-5 2~9 ~~ ~~ ~~ 168 1.5xlo- 6 2 9 189 1.5x1o· 271 269 270 270 193 
Saline Control 271 271 262 268 191 
*Ratio:- Ratio of amount of precipi tate t o amount of 
precipitate obtained in saline control{no 
inhibitor present) 
Ratio* 
0.46 
.70 
.94 
1.01 
1.01 
0.55 
• 78 
.96 
.98 
1.02 
0.~7 
• 2 
.88 
.99 
1.01 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
D. Whole Serwn 
Average 
Drug Dilution Klett Readings Average -Blank 
L-136 1.5xlo-j 211 214 212 212 133 
1.5x10- 234 260 250 248 169 1.5xlo-~ 295 
-
295 216 
1.5xlo-6 313 291 318 307 228 1.5x1o- 304 316 317 312 233 
Saline Control 316 320 321 319 240 
L-172 1.5xlo-2 198 199 203 200 124 1.5x10-~ 259 249 252 25, 177 1.5x1o-5 300 312 301 30 228 1.5x10-6 314 304 308 309 233 
1.5x1o- 310 313 309 311 235 
L-161 5 -2 225 227 221 224 1~8 1. xlO 3 1.5x1o-
4 
259 263 260 261 1 5 
1.5x1o- 302 302 302 302 226 1.5xlO-~ 318 317 316 317 241 
1.5xlo- 320 320 314 318 242 
Saline Control 322 320 310 317 241 
ii-Ratio:- Ratio of amount of precipitate to amount of 
precipitate obtained in saline control (no 
inhibitor present} 
Ratio·n· 
0.55 
.70 
.90 
.95 
.97 
. 52 
·74 
.95 
-97 
.98 
.61 
·11 
.94 
1.00 
1.00 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
E. Globulin Fraction 
Average 
Drug Dilution Klett Readings Average - Blank 
L-13.5 1 • .5xlo-2 136 134 135 60 
1 • .5xlo-.3 19.5 201 198 123 
1 • .5xlo-~ 228 2~6 232 1.57 1 • .5xlo-6 228 2 6 237 162 1 • .5xlO- 221 245 233 158 
L-134 1 • .5xlo-~ 171 16.5 168 93 
1 • .5xlo-
4 
208 198 203 128 
1 • .5x1o-5 246 237 242 167 1.5x10- 255 241 248 173 
1.5xlo-6 258 243 251 176 
L-1 1.5x10-2 147 ~~ 152 148 73 1.5x1o-a 190 192 190 115 
1.5.x1o- 241 237 237 238 163 1.5xlo-~ 252 255 252 2.53 178 
1 • .5xlo- 248 252 256 252 177 
Saline Control 251 244 249 248 173 
*Ratio:- Ratio of amount of precipitate to amount of 
precipitate obtained in saline control (no 
inhibitor present) 
Ratioif-
0.35 
.71 
.91 
.94 
.91 
• .54 
·74 
.97 
1.00 
1.01 
0.~2 
• 7 
.94 
1.03 
1.02 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen 
F. Globulin Fraction 
Average 
Drug Dilution Klett Readings Average -Blank 
L-136 l.5xlo-2 148 146 1~8 147 70 l.5xlo-3 202 207 1 3 197 120 1.5x1o-~ 245 251 229 242 165 
1.5.xlo-6 250 252 229 244 167 1.5x1o- 251 251 240 247 170 
L-172 1.5xlo-2 153 153 148 151 74 1.5x1o-~ 218 205 205 209 132 
1.5x1o- 237 236 245 239 162 1.5xlo-~ 249 246 250 248 171 
1.5x1o· 235 249 243 242 165 
L-170 1.5xlO-~ 139 139 ltO 139 62 1.5x1o- 165 167 1 8 167 90 1.5xlo-~ 223 214 222 220 1~3 1.5.xlo-6 245 240 241 242 1 5 1.5xlo- 239 245 228 237 160 
Saline Control 235 247 241 241 164 
*Ratio:- Ratio of amount of precipitate t o amount of 
precipitate obtained in saline control (no 
inhibitor present) 
RatiO* 
0.43 
·13 
1.01 
1.02 
1.04 
o.~5 
• 1 
.99 
1.04 
1.01 
0.38 
.55 
.87 
1.01 
0.98 
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TABLE II 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
G. Globulin Fraction 
Average 
Drug Dilution Klett Readings Average - Blank 
L-137 l.Sxlo-2 1.58 1.59 1.58 82 
1 • .5xlO-~ 21.5 211 221 216 140 
1 • .5x1o- 247 248 2.52 249 173 
1 • .5xlo-~ 2.51 
-
2.57 2.54 178 
1 • .5x1o- 2.56 2.54 260 2.57 181 
L-161 l.Sxlo-2 1.57 1.56 163 1.59 83 
l.Sxlo-3 20.5 20~ 208 20.5 129 1 • .5x1o-~ 241 23 24.5 240 164 
1 • .5xlo-
-
2.51 249 2.50 174 
l.Sxlo-6 2.54 242 241 246 170 
L-208 1 • .5xl0-2 132 133 133 .57 
1 • .5xlO-~ 198 196 198 197 121 
1 • .5x1o- 24.5 
-
2.51 2~8 172 1 • .5xlo-~ 2.54 26.5 262 2 0 184 
1 • .5x10- 2.5.5 262 261 2.59 183 
Saline Control 2.5.5 25~ 2.54 2.5.5 179 
it-Ratio:- Ratio of amount of precipitate to amount of 
precipitate obtained i n saline control (no 
inhibitor present) 
Ratio* 
0.46 
• 78 
.97 
1.00 
1.01 
0.46 
.72 
.92 
.97 
.9.5 
.33 
.68 
.96 
1.03 
1.02 
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TABLE II - H 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen 
Summary of Tests with Most Concentrated Drug Solution 
Drug 
L-208 
L-173 
L-135 
L-170 
L-171 
L-137 
L-172 
L-136 
L-205 
L-134 
L-161 
L-1 
Whole Serum 
Ratio 
0.41 
.45 
.46 
·47 
.48 
.50 
.52 
.55 
.55 
.58 
.61 
·47 
Globulin Fraction 
Ratio 
0.33 
.54 
.46 
.Lf-2 
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TABLE III 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
Drug Klett Readings Average Average-Blank Ratio* 
L-208 131 133 135 133 54 0.24 
L-204 137 136 135 136 57 .26 
L-173 139 140 137 139 60 .27 
L-171 141 141 140 141 62 .28 
L-205 140 141 140 140 61 .28 
L-135 144 151 137 144 65 .29 
L-172 144 144 143 144 65 .29 
L-161 147 150 153 150 71 .32 
L-136 152 151 151 151 72 
-33 
L-170 156 153 150 153 74 ·33 
L-202 152 154 152 153 74 ·33 
L-134 155 154 154 154 75 .34 
L-203 154 153 154 75 
-34 
L-206 159 161 157 159 80 .36 
L-137 164 163 163 163 84 .38 
L-207 172 176 175 174 95 ·43 
L-201 179 177 177 178 99 ·45 
L-1 135 135 132 134 55 .25 
Saline 
Control 
305 293 296 300 221 
301 306 297 
*Ratio:- Ratio of amount of precipitate to amount of precipi-
tate obtained in saline control(no inhibitor present) 
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TABLE III 
Hapten Inhibition Experiment with Antiserum to 
L-lSS Using L-lBG as the Precipitating Antigen. 
Simple 
Compound Klett Readings Average Average-Blank Ratio-tt-
1-a 220 218 218 219 139 o.63 
1-b 219 216 219 218 138 .63 
3 228 236 230 231 151 .69 
6 273 262 277 271 191 .87 
5 272 272 276 273 193 .88 
12 275 277 268 273 193 .88 
13 270 275 274 273 193 .88 
9 286 278 274 279 199 .90 
7-a 281 278 284 281 201 .91 
7-b 285 284 278 282 202 .92 
8 292 287 285 288 208 .95 
4 292 297 283 291 211 .96 
11 293 297 295 295 215 .98 
2 298 297 301 299 219 1.0 
Saline 
Control 299 298 305 
298 300 300 300 220 
*Ratio:- Ratio of amount of precipitate to amount of pre-
cipi tate obtained in saline control(no inhibitor 
present) 
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TABLE IV 
Subst1tuted .P1per1dines Tested for Local Anesthetic Action 
Free Base 
L-1 
L-134 
L-13.5 
L-136 
Molecular Weight 
of Hydrochloride 
312.8 
311.9 
298.8 
312.8 
L-171 
L-172 
L-173 
L-201 
Free Base 
0 
-51-
TABLE IV 
Molecular Weight 
of Hydrochloride 
339.9 
-52-
TABLE I V 
Free Base 
L-203 
L-205 
L-206 
Molecular Weight 
of Hydrochloride 
311.9 
327.9 
327.9 
303.9 
Free Base 
1 - a Two different 
1 - b solutions of 
3 
5 0 
7 - a Two different 
7 - b solutions of 
( CH3 ) 3N 
9 
/ CH3 
HOCH2CH2 N Cl 1"\ 
12 
CH
3 
CH
3 
( C2H.5 ) 2 NH· HCl 
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TABLE IV 
Molecular Weight 
of Hydrochloride 
341.9 
2 
~0 0 S CH CH -~ I 3 3 
" ocH CH - N Cl 
2 2 I ""-. 
11 CH3 CH3 
( CH3 ) 2NH• HC1 
13 
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TABLE v 
The Toxicities of Variously Substi t uted Piperidines 
Intravenous Subcutaneous 
Drug L.D. 't S. E. Drug L.D. ".t S.E. 
mg . /kg . in mice mg ./kg . in mice 
L- 136 115 '!' 6 L- 204 1600 -r 69 
L-135 100 ;t 9 L- 202 1550 ".!185 
L- 202 74 ~ 4 L- 134 Boo t 64 
L- 203 59 3' 2 L- 208 730 !: 43 
L- 134 52 ~ 2 L- 203 690 '!.117 
L- 137 42 :!" 4 L- 589 :t 65 
L- 201 35· 1' 2 L- 207 510 ~ 24 
L- 204 35 ~ 2 L-135 500 ~ 11 
L- 161 35 .: 1 L- 206 410 !' 48 
L- 172 34 ~ 1 L-161 386 1' 27 
L- 170 31 ~ 4 L- 205 345 t 29 
L- 207 27 :!" 1 L- 136 330 % 39 
L- 208 26 % 1 L- 171 305 ~ 30 
L- 22 ~ 1 L- 170 290 ~ 39 
L-206 20 r 1 L-137 235 -.t 15 
L- 171 18 = 1 L-201 156 't' 17 
L- 205 18 "t' 1 L- 173 155 ~ 24 
L-173 9 !: 1 
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TABLE VI 
The Local Anesthetic Action of 
Variously Substituted Piperidines 
Drug % Solution T (minutes) Drug % Solution s (minutes) 
L-173 0.25 35 L-170 1 50 
L-201 0.25 30 L-206 1 45 
L-161 1 23 L-161 1 39 
L-172 1 21 L-171 1 34 
L-206 1 19 L-134 1 30 
L-205 1 15 L-202 1 28 
L-207 1 15 L-203 1 23 
L- '1 10 L-135 1 8 ' 
L-208 1 5 L-137 1 7 
L-204 1 5 L-136 1 3 
L-136 1 0 
L-134 1 0 T - "durati on of topical anesthe-
s i a was determined by appl i -
L-202 1 0 cation of a solution of the 
anestheti~ ••••• t o t he 
L-137 1 0 r abbit's cornea" 
L-171 1 0 s - "subcu taneous anesthesi a was 
L-203 1 0 
determined on the guinea 
pig's skin" 
L-170 1 0 
L-135 1 0 
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TABLE VII 
Comparison of Hapten Inhibition with Local Anesthetic Data. 
Drug Hapten Inhibition Constant Local Anesthetic Action 
Second Series First Series T s 
L-208 1.12 1.47 5 
L-204 o.89 5 
L-173 .81 1.00 0.25%- 35 
L-171 • 72 0.79 0 34 
L-205 .72 .38 15 
L-135 .67 . 85 0 8 
L-172 .67 .56 21 
L-161 .50 .28 23 39 
L-136 .45 .56 0 3 
L-170 .45 .89 0 50 
L-202 
-45 0 28 
L-134 .41 .32 0 30 
L-203 .41 0 23 
L-206 
-34 19 45 
L-137 .28 .50 0 7 
L-207 .18 15 
L-201 .14 0.25%- 30 
-57-
TABLE VIII 
Comparison of Hapten I nhibition and Pharmacological Data. 
Local 
Drug Mol.wt. Hapten Inhibition Toxicity Anesthetic 
Constant Action 
Second First 
Series Series i.v. s.c. T s 
L-208 304 1.12 1.47 26:tl 730t43 5 
L-135 299 0.67 o.85 100t9 500~11 0 8 
L-204 312 0.89 35%2 1600%69 5 
L-172 314 .67 .56 J4:t1 21 
L-136 313 
-45 .56 115~6 330~39 0 3 
L-134 312 .41 .32 52t2 8oot64 0 30 
L-205 328 • 72 .38 18~1 345:!:29 15 
L-161 326 .so .28 35~1 386:!27 23 39 
L-202 32ti 
-45 74't4 1550tl85 0 28 
L-206 328 
·.34 20~1 410~48 19 45 
L-203 326 
-41 59~2 690~117 0 23 
L-171 340 • 72 .79 18!1 305:!'30 0 34 
L-137 342 .28 .50 42'14 235!15 0 7 
L-207 .342 .18 27~1 510!:24 15 
155:!'24 
0.25% 
L-173 402 .81 · 1.00 9~1 35 
156t17 
0.25% 
L-201 390 .14 35t2 30 
-58-
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PART II 
THE INCORPORATION OF c14-CARBOXYL-LABELED 
LEUCINE BY SERUM PROTEINS 
INTRODUCTION 
Quite recent l y many workers have a t tempted to study 
the reactions of antigens and antibodies with the aid of 
isotopic tracer methods and it is probable that these 
methods· will be used ext ensively in the future. However, 
most of the studies made to date have been carried out by 
labeling the material to be studied with an element or 
group not normally present i n the molecule itself. Al though 
labeling the normal constituents of a protein is a time 
consuming and laborious process as compared to other methods 
of labeling it is certainly the most satisfac tory method 
for the carrying out of cert ain experimen ts in which un-
changed native molecular s t ructures are required. 
The grea t est number of i nvestigations have been carried 
out by iodinating the protein material with rl31. Butement 
(1) was one of the first workers to inves tiga t e t he possi-
biliti es of labeling with radi oactive iodi ne and he found 
that iodination had little or no effect upon agglutinating 
ant i bodies for pro teus vulgaris.. He is pe r haps t he only 
worker t o have considered t he ef fect of t he dis t r i bution 
of the iodine atoms on t he different protein mole cules. 
Pre ssman and his coworkers have used rl3l t o carry out 
studie s on the "zone of localization"· of antibodies (2-14). 
They prepar ed ant i bodie s directed against spec ific animal 
t issues (usually ra t or mous e kidney, lung , or liver) and 
these antibodies were t hen labeled with radioac t ive iodine 
-67-
and injected into normal rats or mice. The localization of 
these antibodies was then followed. Warren and Dixon have 
studied anaphylactic shock in guinea pigs with rl31-labeled 
bovine gamma globulin (15) (16). Eisen and Keaton (17) have 
studied the precipitation reaction of bovine serum albumin 
and anti-bovine serum albumin using this label. Haurowitz 
and his coworkers (18)(19)(20) have studied the distribution 
of rl31 in rabbits following the administration of iodine-
labeled antigens and similar work has been carried out by 
Dixon, Bukantz and their coworkers (21)(22)(23)(24)(25) in-
cluding studies on rabbits exposed to X-radiation (21). 
Knox and Endicott (26) have measured the rate of disap-
pearance of iodine-labeled bovine serum albumin from the 
blood stream of rabbits. Pressman and Sternberg (27) have 
studied the rate of iodination of antibodies with rl31 and 
later studied the protection of the specific antibody site 
by haptens during iodination (28) . Banks et al. (29) have 
also used rl31 to label antigens and antibodies and have 
conducted hapten inhibition tests with labeled antigens, 
antibodies, and haptens (30). Masouredis et al. (31) have 
carried out precipitation studies with human serum albumin 
labeled with iodine and Gitlen et al. (32) have used this 
isotope to estimate the half life of protein antigens. Latta 
(33) has also measured the blood and tissue concentrations 
of rl3l after the administration of rl31-labeled antigen. 
s35 has been used also as a label for antigens and 
I 
antibodies. Boursnell et al. (34) used~~-dichlorodiethyl-
sulfone to tag proteins and Pressman et al. have also used 
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s35 for a label in their localization studies by diazotizing 
aminobenzenesulfonic acid onto the antibodies (35). 
Banks et al . (36) used p32 in the phosphorylation of 
proteins and investigated the fate of these proteins when 
injected into rabbits. A number of workers are continuing 
this type of work and many of the results are appearing in 
the Journal of Immunology. 
Fewer workers have attempted to isotopically label the 
normal constituents of the antigen or antibody molecule but 
this has been done successfully. The earliest studies with 
labeled antibodies were those of Schoenheimer, Heidelberger, 
and their coworkers (37)(3 8 )(39). They fed Nl5-labeled amino 
acids to rabbits and followed the incorporation of the heavy 
nitrogen into the serum proteins. Libby and his coworkers 
(40)(41) have determined the fate of tobacco mosaic virus in 
mice by following p32 activity which was incorporated into 
the virus from the plant on which it grew. Boursnell et 
al. (34) and their coworkers have carried out investigations 
on the antig en-antibody reaction of the lipovitellin-
antilipovitellin system by using lipovitellin isolated from 
the eggs of hens receiving p32-labeled phosphate ion. This 
group studied the antigen-antibody precipitation reaction 
of the system but because of the complexity of the antigen 
used and the reaction of the antibody with phospholipids 
present they concluded that this was a poor system to study 
quantitatively (29)(36)(42)(43)(44). They also studied the 
fate of p32 containing proteins in vivo (36)(44). Kooyman 
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and Campbell (45) were the first to use a c14-labeled amino 
acid in this type of work and they carried out exper~ents 
similar to those of Schoenheimer and his coworkers. Keaton 
and Dreyfus (46) have studied the incorporation of c14-tagged 
glycine into antibody proteins in vitro in some experiments 
undertaken to critically evaluate the work on the in vitro 
synthesis of proteins by tissue slices and homogenates. 
Similar exper~ents have been performed by Ranney and London 
(47). A report on the work discussed in this thesis using 
c14-labeled leucine has also been given <48). 
As stated, Schoenheimer, Heidelberger and their coworkers 
fed Nl5-labeled amino acids to rabbits and followed the in-
corporati on of the heavy nitrogen into the serum proteins. 
Their conclusions were that antibody proteins, like other 
proteins, take up the heavy nitrogen at a rapid rate during 
the process of formation. They found that this occurs even 
when the concentration of circulating antibody is diminishing, 
indicating that new antibody is being formed though the rate 
of degradation is greater than the rate of synthesis. The 
authors also concluded that injected antibody globulin 
(passively transferred antibody) either did not incorporate 
the isotope or else .did so with the loss of its specific 
antibody properties, since rabbit antibody injected into a 
normal rabbit receiving labeled glycine showed only a very 
small uptake of heavy nitrogen and this seemed to be a non-
specific effect. 
When c14 became available in sufficient quantities 
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Kooyman and Campbell <45) decided to repeat the work of 
Schoenheimer et al. with this very easily handled tracer. 
c14 offers the advantage of being detectable in very low 
concentrations in a relatively simple manner. In some 
preliminary experiments Kooyman and Campbell prepared 
cl4-labeled leucine and administered this to rabbits by 
intraperitoneal injections. The rabbits used had been 
immunized and while receiving the labeled amino acid they 
also received intravenous injections of different antibody 
solutions. Radioactivity was found in passively transferred 
rabbit antibody but none was found in passively transferred 
horse antibody. Kooyman and Campbell thought it was very 
probable that an exchange took place with the passive 
homologous antibody. Since there was some question re-
garding the quantitative significance of their data, which 
contradicted the earlier conclusions of Schoenheimer and 
Heidelberger, the following experiments were performed. 
They are essentially a repetition of the earlier work by 
Kooyman and Campbell but were performed under more precise 
quantitative conditions. 
EXPERIMENlAL 
The synthesis of carboxyl-labeled leucine. Leucine was 
chosen for these initial experiments because it occurs in 
large amounts in serum proteins and also its synthesis from 
c14-labeled barium carbonate is not too difficult. The 
activity incorporated into the leucine had to be somewhat 
arbitrary but considering the earlier work it was decided 
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to prepare leucine with an activity of about 10,000 counts 
per minute per mg in the counter used. This corresponds to 
lo4 x . lo3 or 107 counts per minute per gram. Allowing a 
factor of 20 for the efficiency of the counter the material 
should have a specific activity of 
2 X 9 x lo- 2 
millicuries per gram. As yields of about 30% were expected 
it was decided that the synthesis would be started from 
about 0 . 4 millicuries of barium carbonate and this should 
yield about 1 . 5 gr ams ofa'/- leucine of suitabl e activity . 
A number of methods for the preparation of leucine 
have been described , the most important of these being I . 
Isocaproic acid ~ bromoisocaproic acid -t leucine, II . 
Strecker synthesis starting from isovaleraldehyde , and I II . 
Saponification followed by decarboxylation and hydrolysis 
of isobutyl aminoacyl malonic ester . Kooyman (49) had worked 
out a synthesis of cl4-carboxyl- labeled leucine following 
I and so it was decided to attempt to repea t this synthesis . 
Although this method is relatively simple it has the dis-
advantag e of starting with a relatively impure material 
(isoamyl bromide) which yields isomeric compounds in the 
final product . Since this work was undertaken Borsook et 
al . {50) have published a synthesis of cl4-labeled leucine 
using the Strecker synthesis and as they obtain the 
isovalereldehyde in hig h purity their synthesis has the 
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advantag e of yielding a purer product. 
Kooyman (49) had adapted the method of Cheronis and 
Spitzmueller (51) to convert the bromoisocaproic acid to 
leucine and doing this reported a high overall yield. 
However, preliminary trials with inactive material failed 
to reproduce these high yields and modifications of his 
procedures were used. 
The synthesis was carri ed out according to the follow-
ing series of reactions-
Baco3 + 2HCl -+ BaCl2 + C02 + H20 
CH 0 ~ 3~ CHCH2CH2- c ~ CH3 "-OMgBr 
hydrolysis 
) 
CH 0 3
"- CHCH CH - C ~ 
CH "" 2 2 ' oH 3 
b) 
CH 0 3
'-CHCH CH - C~ + 
CH "" 2 2 ' oH 3 
via ) 
acyl bromides 
c) CH 0 3 
'- CHCH CHBr - c' + NH3 CH / 2 '- OH 3 
) 
NH 
CH \ 2 0 + HBr 
3 "- CHCH CH - C~ CH _, 2 ' OH 
3 
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Eastman (white label) isoamyl bromide was distilled 
several t~es collecting the fraction coming over at 117° -
0 119 c. and a solution of isoamyl magnesium bromide was 
prepared from this. One hundred millimoles (2.4 g) of 
clean magnesium ribbon was placed in a round bottom flask 
having a condenser with a drying tube on it. A solution 
of one hundred millimoles (15.1 g) of the isoamyl bromide 
in 45 ml of anhydrous ether was slowly added while stirring 
vigorously. There was no difficulty in starting the re-
action especially if a fairly concentrated solution of the 
isoamyl bromide was added initially. After the reaction 
had slowed to the point of nearly stopping the reaction 
mixture was heated in a water bath at 37° c. for a period 
of about 15 minutes. Unreacted magnesium was removed by 
filtration under pressure through a sintered glass filter 
into a flask attached to the carbon dioxide apparatus. 
The 100 millimoles of isoamyl bromide corresponded to an 
excess of 150% over what was required to react with the 
carbon dioxide produced. 
The apparatus for the carbonation of the Grignard 
solution is shown in Figure r. Separating funnel A con-
tained 6 N hydrochloric acid and emptied into tube B which 
contained the sample of radioactive barium carbonate. 
The capacity of B was about 3 ml. The three necked flask 
C contained inactive barium carbonate which furnished 
carbon dioxide to wash the labeled carbon dioxide through 
the apparatus. Drying tower D was filled with anhydrous 
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calcium chloride and the washing tower E contained concen-
trated sulfuric acid. Stopcock F was used in order to be 
able to evacuate the apparatus. The washing of the carbon 
dioxide through the concentrated sulfuric acid seemed to be 
necessary. G was another stopcock which served to cut off 
the apparatus when evacuated from the flask H to which the 
Grignard reagent was transferred. Before a run was started 
the whole apparatus was evacuated and stopcocks F and G 
were then closed. 
The Grignard reagent was filtered into flask H which 
was immediately immersed in a dry ice-methyl cellosolve 
bath. Flask H was then evacuated until the ether solution 
began to boil and then stopcock I was closed. A few drops 
of the hydrochloric acid were slowly admitted to tube B 
containing the 0.4 millicuries of barium carbonate. This 
corresponded to about 40 mg of the 3% tagged material sup-
plied by the Atomic Energy Commission. After this had 
reacted more hydrochloric acid was slowly admitted and 
allowed to overflow into the flask C which contained 7.86 
grams of pure inactive barium carbonate. In general a 
few glass beads were also placed in flask C as they seemed 
to aid in the mixing of the acid and the solid material. 
The pressure was allowed to slowly increase to about 70 em. 
and then stopcock G was slowly opened. Flask H was gently 
shaken while the gas was being absorbed. The fall in 
pressure virtually ceased in about 4-5 minutes at which 
time stopcock G was closed and F opened. Flask H was 
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disconnected and 15 grams of crus hed ice was added to it . 
Thirty five ml of 6 N sulfur ic acid was added slowly with 
shaking and the mixture was allowed to warm up to room 
temperature. The con tents of the flask were rinsed into 
an apparatus for continuous extraction with ether. 
The aqueous layer wa s extracted for four hours and the 
ether extract was dried over anhydrous sodium sulfate to 
remove traces of magnesium salts. The isocaproic acid was 
separated from the non-acidi c reaction products by ex-
traction with 4 N sodium hydroxide , using three porti ons of 
12, 4, and 4 ml respectively. This aqueous extract wa s 
washed once with 5 ml of ether, acidified and extracted with 
ether. The solution was dried over anhydrou s sodium sulfate 
and t hen concentrated u nder r educed pressure. 
The bromination of the small amount of isocaproic acid 
had proved r a t her difficult and it was found advantag eous 
t o distill the crude isocaproic acid i n a small vacuum still 
at this point and then a small amount of dri ed s tockroom 
isocaproic acid was used to r inse the tagged material into 
a one hundred ml round bottom flask for the bromination 
procedure. Four-tenths of a gram of r ed phosphorus wa s 
added t o t he ac i d and a condenser carry ing a small separa-
tory f unnel and a gas outlet tube was f i tted to the round 
bot t omed flask . Twelve grams of bromine which had been 
dried over concentrated sulfuric acid were added through 
t he condenser in the course of four hours while ~eeping 
the temperature of t he flask at 50 - 60° C • . The flask 
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was then kept at 70 - 75° c. f or another three hours and it 
was finally heated on a boiling water bath for one hour. 
The mixture was allowed t o s t and overnight at room tempera-
ture and on the f ollowing day 15 grams of crushed ice, 15 ml 
of chloroform, and 5 ml of a 1% solution of sodium metabi-
sulfite were added. The mixture was stirred for fifteen 
minutes and the brominated acids were extracted with chloro-
form after making sure the aqueous phase was quite acid by 
adding a little sulfuric acid. (This method of bromination 
is essentially the same as described by Hickenbottom (52).) 
The chloroform solution was concentrated in vacuo and the 
brominated acids were distilled in vacuo, the main fraction 
boiling from 88 - 90° c. at 2 mm. pressure. A little un-
reacted isocaproic acid was collected with the distillate. 
The tube containing the distillate was transferred to a pyrex 
tube 45 em. in length and 28 mm. in outside diameter. This 
avoided the loss of any material during the transfer. The 
large pyrex tube was a standard combustion tube which was 
capable of withstanding t he 10 atm. pressure produced in 
the trea tment with liquid ammonia. 
Dry ammonia gas was condensed into the pyrex tube 
containing the mixture of bromoisocaproic acid and isocaproic 
acid making use of a drying tube containing sodium hydroxide 
pellets to keep the system dry. The tube was maintained at 
- 80° c. and sealed when 25 ml of ammonia had been condensed. 
The tube was allowed to warm up to room temperature and the 
contents were mixed. The tube was allowed to stand for 
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forty-eight hours at room temperature, encased in an iron 
pipe as a safety measure. The tube was cooled again to 
-80° c. and opened. The ammonia was allowed to slowly 
evaporate off . The last traces were removed by evacuating 
0 the tube while keeping it at 40 c. 
The resulting solid product was repeatedly washed with 
95% ethyl alcohol using a total volume of 75 ml. The product 
was recrystallized from 50% alcohol as described by Marvel 
(53). The final product melted with decomposition below 
the prescribed 332° c. but the benzoyl derivative was pre-
pared which melted at the required l41°c. A sample prepared 
by Dr . Kooyman was analys.ed and on duplicate determinations 
gave for the total nitrogen 10. 8 and 10.8%, for amino 
nitrogen by the Van Slyke method 10. 7 and 10.6%, for alpha 
amino nitrogen by the ninhydrin method 10. 8 and 11.0%, as 
compared to the theoretical amount of nitrogen of 10.68%. 
The final yield was about 1.5 grams which corresponds 
to an overall yield on barium carbonate of about 30%. No 
attempt was made to racemize the mixture as this would have 
involved the loss of valuable material. The presence of the 
ct isomer would not influence the planned experiments as the 
object was only to obtain a high level of radioactivity in 
the serum proteins . The solution from the recrystallization 
yielded a little more product upon concentration and addition 
of alcohol . 
The measurement of the radioactivity. Usually the measure-
ment of c14 activity is accomplished by converting the 
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material to carbon dioxide and either determining the 
activity of the gas or r eacting the gas with barium 
hydroxide and counting the activity of the barium carbonate 
(54) . However , as all the materials to be counted in this 
work were protein in nature it was decided to investigate 
the possibility of counting the material as a protein 
precipita te . From an absorption standpoint counting as 
protein material would be advantageous since barium car-
bonate is only about 6.1% carbon and protein material is 
at least about 30% carbon. However , it is difficult to 
obtain smooth reproducible surfaces on the protein pre-
cipitates and many procedures had to be tried in order to 
determine the most satisfactory procedure for mounting the 
protei n material. The most important observation made was 
that the material had to be relatively free from water in 
order to avoi d caking and cracking of the sample surface. 
The procedure finally adopted for preparing the samples 
was the following . The protein material to be counted was 
suspended in 1% saline and washed three times in a small 
centrifuge tube. The material was then finely ground in 
95% ethyl alcohol and this was f ollowed by three was hings 
in 95% ethyl alcohol and three washings in anhydrous ethyl 
ether. About five to twenty mg of this material was made 
into a slurry with a few ml of anhydrous ether and this 
was transferred to a brass cup which was fitted so as to 
deposit the residue upon evaporation of the ether on to a 
weighed aluminum disk. The disk had a circular exposed 
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surface of one centimeter in radius which resulted in the 
residue having a surface density of about 1.5 to 6.5 mg 
per cm2. The use of some adhesive material on the aluminum 
disks was tried but in general this was not necessary. 
Quite often the material would cake and crack on the disk 
but when this occurred pulverizing the material with a 
little anhydrous ether and allowing this to evaporate off 
gave a uniform surface. Care had to be taken to avoid 
swirling the slurry as this caused uneven deposition of the 
solid. Self absorption curves were plotted using several 
different tagged protein materials and these were found to 
be very similar to the curves for barium carbonate (54)(55) 
(56). A curve plotted using the antigen-antibody precipi-
tate material from the experiment with rabbit 63 described 
later is shown in Figure 2. The values of the specific 
activity of the samples of less than 2.5 mg per cm2 were 
used to evaluate the specific activity, i7D , of very thin 
samples. Self scattering is apparently not too great in 
these samples. The lower curve in Figure 2 gives the ratio 
of this specific activity of a very thin sample to )7 the 
observed specific activity of a thick sample. As can be 
seen over this relatively narrow range the curve is practically 
linear. This curve was used to correct the radioactivities 
of all the samples measured for self absorption. Sufficient 
data were available to show that all the protein samples 
gave similar self absorption effects. The measurements of 
the radioactivity are given later with the nine-tenths 
-80-
statistical error (57) . The experimental errors introduced 
are undoubtedly much greater than this . 
The source of the radioactivity of the proteins. One 
question that arose in the counting of the radioactivity 
was to what extent the c14 was still present as leucine . 
Samples of rabbit serum albumin that had been tagged in the 
experiments of Dr . Kooyman were analysed for specific 
leucine activity . This was carried out by digesting a 
sample of the albumin in the presence of ~ large excess of 
inactive pure ~-leucine . The use of hydrochloric acid 
seemed to be the most satisfactory for carrying this out. 
In general samples were digested for 24 hours at 100 -120° C. 
and allowed to stand for some time at room temperature . 
The samples were evaporated to dryness in a desiccator and 
the residues were dissolved in water and neutralized with 
a small amount of sodium hydroxide . The solutions were 
decolorized by boiling for two minutes with norite and 
filtering . The solutions were again evaporated to dryness 
in a desiccator . The residues were redissolved in a small 
amount of water, and ethanol was added. The solutions 
were allowed to stand overnight in a refrig erator until a 
small amoun t of precipitate had formed . The precipitates 
were filtered out, washed with a mixture of alcohol and 
ether , and allmved to dry . The specific activity of this 
material whic h should be largely leucine only corresponded 
to 50 - 55% of the total activity of the albumin. No 
attempt has been made to investigate the distribution of 
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the radioactivity any further but the determination of 
where the rest of the activity is would furnish an in-
teresting problem. 
All the counting was done with a ttTracerlabn Geiger-
Mueller counter using a "64" scaler. The end window of 
the Geiger tube had a thickness of 1.4 mg per cm. 2 • 
The incorporation of cl4 activity £l the blood proteins of 
rabbits receiving cl4-carboxyl-labeled~-leucine. The 
primary purpose of these investigations was to determine if 
passively transferred antibody molecules could incorporate 
radioactivity given to an animal in the form of a labeled 
amino acid. To determine this the following experiments 
were carried out. A healthy male rabbit (Rabbit 63) weigh-
ing eight pounds had been immunized against bovine globulin 
jD-azophenylarsonate (RBG) receiving t he last i mmunizing 
injection on the day this experiment started. The rabbit 
then received three dai ly intraperitoneal injections 
(day 0, 1, and 2) of 30 ml of a 1% solution of the labeled 
leucine. The rabbit thus received an amount of radio-
active material equivalent to about 9 x 106 counts per 
minute in the counter used. The leucine solution had been 
sterilized by filtration through a Seitz filter. On the 
third day it received two intravenous injections of a 
rabbit antiovalbumin solution receiving a total of 27 ml 
of solution. This solution contained 33 mg of protein per 
ml and gave 6.1 mg of precipitate per ml when titrated with 
ovalbumin. On the next day (day 4) the animal received 
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ll ml of a horse antibody solution which contained 49 mg 
of protein per ml and gave 12.5 mg of precipitate per ml 
when titrated with type I pneumococcus polysaccharide and 
17.0 mg of precipitate per ml when titrated with type II 
p neumococcus polysaccharide. On day f ive 70 ml of blood 
were taken from the rabbit's ear and this was defibrinated 
by shaking with glass beads . The rabbit then received 35 
ml of sterile saline. On day seven 60 ml of blood were 
taken from the ear and defibrinated. The defibrinated 
blood samples were centrifuged and the serum was removed. 
Small portions of t he serum samples were titrated with 
bovine globulin)O-azophenylarsonate to determine t he optimum 
ratio. Using this r a tio the active antibody was precipitated 
from 20 ml port ions of the sera. The samples were all.owed 
to remain 48 hours i n t he refrigerator before centrifuging 
off the precipitate . The precipitates were washed 3 times 
with cold saline and were then prepared for counting as 
outlined above . Background was determi ned before and after 
each sample was count ed and after the counter bad been 
allowed to run continuously for a twelve hour period it was 
f ound to be practically constant. The radioactivities 
measured with the nine-tenths statistical error are given 
in Tables I and II . These values were corrected t o counts 
per minute per 10 mg of sample making the necessary cor-
rection for self absorption and the resulting values were 
listed. 
In the earlier work the question of the effect of 
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complement being bound by the precipitates was raised. 
Complement is a naturally occurring substance or group of 
substances present in serum which is needed in addition 
to antibody for the bactericidal and hemolytic reactions 
of immune serum (58). Complement is removed to a large 
extent by the specific precipitation of antigen and antibody, 
being part of the precipitate complex. The presence of 
radioactive complement would have little effect upon the 
specific activity of the active antibody precipitate but 
would have a marked effect on precipitates of low specific 
radioactivity. It was suggested that the radioactivity of 
the passive antibody precipitates in the experiments of Dr. 
Kooyman might be due to complement present. Assuring the 
removal of a material as complex as complement would be 
very difficult but it is known that complement activity is 
destroyed by heating the serum at 56° c. for half an hour. 
The supernatants from the active antibody precipitati ons 
which should have little complement activity in any case 
were therefore heated at 56° c. for half an hour. They 
were then tested in the standard manner for complement 
activity (59) and were found to be negative. This still 
did not completely assure the removal of any material 
which might be carried down with the precipitates in a 
more or less no~specific manner but it at least made it 
rather unlikely. The solutions were recentrifuged and 
titrations were run with ovalbumin to determine the optimal 
ratios for precipitating the passive rabbit antibody and 
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the precipitations and counting were carried out as for the 
active antibody. In a similar manner the horse antibodies 
were precipitated with a mixture of the two polysaccharides 
in the correct proportions and counted. The results are also 
shown in Tables I and II . 
As these results were contrary to the earlier work it 
was decided to repeat the experiment with the same animal. 
The rabbit received a few more injections of the immunizing 
antigen and then on day twenty four it received an intra-
peritoneal injection of 30 ml of the 1% tagged leucine 
solution. Over the next two days it received four intravenous 
injections of 10 ml of a rabbit antiovalbumin solution. 
This solution gave 4.5 mg of precipitate per ml when titrated 
with ovalbumin. On the next day (day 27) 55 ml of blood 
were taken from the animal and this was treated in the same 
manner as were the previous samples. The results are given 
in Tables I and II. As shown the passively transferred 
rabbit antibody was again found to contain no radioactivity. 
For a further check on the above results the experiment 
was repeated with a different animal and different antigen-
antibody systems. A healthy female rabbit (Rabbit 361) 
weighing about seven pounds received a long series of in-
jections of crystalline bovine serum albumin solution and 
had a high titer of anti-bovine serum albumin antibodies . 
On the three days following the last immunizing injection 
{day 0, 1, and 2) it received 27, 24, and 20 ml of a 1% 
solution of the labeled leucine. On the next two days 
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(day 3 and 4) it received four 10 ml intravenous injections 
of a solution of rabbit anti- bovine globulin p -azophenyl-
arsonate serum. This material gave 10. 9 mg of precipitate 
per ml when titrated with bovine globulin J - azophenylarsonate. 
The rabbit was then bled on days 5, 6, 13, 20, and 27 taking 
40, 65, 40, 30,and 30 ml of blood on the respective days . 
The bleedings were all from the ear and after each bleeding 
the animal received an intraperitoneal injection of sterile 
saline. Between the third and fourth bleedings the im-
munizing injections were again started. The samples were 
treated in the same manner as before checking for complement 
activity after the removal of the active antibody. In all 
cases the active antibody was precipitated first. The 
amount of antibody in each sample is given in Table VIII, 
and the amount of radioactivity in each precipitate is given 
in 'I'ables V and VI . It is to be noted that the passive anti-
body in this case did show some radioactivity although not as 
much as was found in the earlier work. To determine if this 
radioactivity was merely the result of adsorption the passive 
antibody precipitates were resuspended in saline and again 
washed by the procedure previously outlined. The material 
from the second bleeding showed a real decrease in the amount 
of radioactivity. A different sample of the passive antibody 
material from the second bleeding was washed in a more 
thorough fashion than the other sample and it was found to 
contain an intermediate amount of radioactivity . The data 
are shown in Table VI . 
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It seemed of interest to compare the amount of radio-
activity in the antigen-antibody precipitates with that 
present in the other serum proteins that were available . 
The fibrin from eac h bleeding was washed, dried, and pul-
verized and then rewashed and treated and mounted in the 
same way as the antigen- an tibody precipitates . The fibrin 
activities are g iven in Tabl es IV and VIII and I and v. 
Samples of the erythrocytes from each bleeding were washed 
repeatedly with s aline and were laked with distilled water . 
Ninety five p ercent ethyl alcohol was added to the clear 
solutions and the precipitates were centrifuged out . The 
prec i pitates were treated in the same manner as the other 
materials and assayed for radioactivity . The amounts of 
radioactivity found are given in Ta bles I , V, IV, and VIII . 
The supernatants from the antibody precipitations were 
treated with alcohol and the resulting precipitates were 
likewise treated, mounted , and assayed for radioactivity . 
The amounts of radioactivity found in this material is also 
g iven in Tabl es I , V, I V, and VIII. The variation in the 
amount of radioactivity in counts per minute per 10 mg of 
sample, corrected for self absorpti on, is s hown in the 
graphs of Figures 3 and 4· 
DISCUSSION 
The results obtained in these experiments on t he in-
corporation of a cl4-labeled amino acid by rabbit serum 
protei ns are essentially what one would predict from the 
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heavy nitrogen experiments of Schoenheimer et al. {37){38) 
and do not show the relat ively high r adioactivity in the 
pas sive antibody material that the results of Kooyman <45 ) 
indicated. However, as shown above, in some cases the passive 
antibody material did contain some cl4. This could be re-
moved a t l east to some extent by extended wa shing of the 
precipitate and would thus seem to be non-specific. It is 
to be noted that the passive horse antibody which the earlier 
work had claimed to be inactive was just as radioactive or 
even more radioacti ve than the rabbi t passive antibody again 
indicating tha t both effects are non-specific. In gen€ral 
great care must be exerc i sed in evaluating the meaning of 
radioacti vity in precipitates such as obtained in these 
experiments. A great deal of the radioactivity may be non-
specific (46). This may or may not account f or the results 
obtained by Kooyman (45 ). In some of hi s experiments the 
pas s i ve antibody was precipita ted before precipitating the 
active antibody and one might expect more non-specific material 
to be brought down in the first of a series of antigen-
antibody preci p ita tions. 
It is possible to estimate the half life of the different 
serum cons t ituent s from curves s imilar to those of Fi gures 2 
and 3 if it is assumed t ha t the radioactivity is not part of 
a mol ecule that is reutilized to make more of the same 
material. However, as large samples of blood were taken at 
each bleeding t he data are not too significan t in this regard. 
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The rat e of decrease of activity is what might be expected 
from similar work on man and the rat (60). It is interesting 
t o note that the red cells are still incorporating activity 
when the activity of the other serum constituents is dec~easing 
rapidly. This may not only be a reflection of the much longer 
half life of the cells as compared to the soluble proteins 
but also a reflection of the utilization of preformed material 
in the synthesis of the red cell protein. 
In conclusion it may be stated that while the normal 
c onstituents of a rabbit's serum incorporate radioactivity 
given in the form of an amino acid at a very rapid rate pas-
sively transferred antibodies either do not incorporate this 
radioactivity to any marked extent or else do so only upon 
the loss of thei r specific antibody characteristics. 
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TABLE I 
Rabbit 63 - Immunized Against Bovine Globulin 
1 -Azophenylarsonate and Injected with cl4-Labeled Leucine 
Time in days 0 1 2 3 4 5 
Injection of 30 ml 
cl4 leucine 30 ml 
(1% solution) 30 ml 
Injection of 
rabbit anti- 27 ml 
ovalbumin 
Injection of 
horse antibody 
(SI SII) 
11 ml 
7 24 25 26 27 
30 ml 
20 ml 20 ml 
Bled 70 ml 60 ml 55 ml 
Radioactivity Found 
Counts per min. per 10 mg 
Anti ovalbumin 
Precipitate 0 0 0 
Horse antibody 
Precipitate 10 8 
Anti RBG 
Precipitate 81 68 32 
Red cell 
protein 14 14 66 
Fibrin 144 111 36 
Alcohol ppt. 
from supnt. 117 99 77 
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TABLE I I 
Radioactivity of Antibody Proteins from Rabbit 63, 
Immunized Against Bovine Globulin p -Azophenylarsonate and 
Injected with c14-Labe1ed Leucine 
Bleed 1 
Bleed 2 
Bleed 3 
Bleed 1 
Bleed 2 
Bleed 3 
Bleed 1 
Bl eed 2 
Acti ve antibody - Anti-REG 
Precipitate 
Weight Counts/minute Counts/min . /10 mg 
4-3 mg 35- 7 't 2 . 5 81 
10 . 8 mg 58 . 3 -.!: 2.5 68 
18 . 6 m.g 36. 8 ~ 2 . 0 32 
Pass i ve homologous antibody - Antiovalbumin 
Prec i pitate 
Counts/min. Recounted Counts/min. Weight 
Background 25.5 t 0 . 8 27 . 7 't 1 . 5 
Sample 26 . 1 't o . 8 28.4 't 1.5 
Background 25 . 9 't 1 . 0 26.3 '!' 1.5 
Backgr ound 24. 6 t 0.9 25. 0 '!' 0.8 
Sample 24 . 9 't 0 . 8 27 .2 't o. 6 
Background 25 . 1 '1' 0. 8 26.6 't' 0. 7 
Background 25.3 't 0. 8 
Sample 25.~ ~ 0.6 
Background 25. '!' 0 . 7 
Background 25 . 1 '!: 0 . 7 
Sample 25.4 '!: 0.7 
Background 25.5 ~ 0 . 7 
6.5 mg 
Passive hors e antibody - Anti-SI SII 
Precipitate 
Weight Counts/minut e Counts/min. /10 mg 
9.4 mg 8 .0 "±' 0.4 10 
2.4 mg 2. 0 t' 0 . 4 8 
Errors given are all nine-tenths statistical error. 
Rabbit 63 
Labeled leucine 
Horse antibody 
Rabbit antibody 
Labeled leucine 
Rabbit anti body 
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TABLE III 
Injected Material 
90 ml of a 1% solution. Activity 
of leucine was 11,000 counts per 
minute per mg in the counter used 
11 ml of solution. Solution con-
tained 49 mg of protein per ml and 
gave 12.5 mg/ml of preci~itate with 
S I antigen and 17.0 mg/ml of 
precipitate with S II antigen 
27 ml of solution. Solution con-
tained 33 mg of protein per ml and 
gave 6.1 mg of precipitate per ml 
when titrated with ovalbumin 
Second Experiment 
30 ml of the same 1% solution 
40 ml of solution. Solution gave 4.5 mg of precipitate per ml when 
titrated with ovalbumin 
- 92-
TABLE IV 
Radioactivity in Blood Proteins of Rabbit 63 
Fibrin: 
Weight Counts/minute Counts/minute/10 mg 
Bleed 1 16 . 6 mg 155 1: 3 . 2 144 
Bleed 2 19.9 mg 128 "!" 3 . 1 111 
Bleed 3 17 . 3 mg 39 . 3 '! 1 . 5 35 . 5 
Red cell protein: 
Weight Counts/minute Counts/minute/10 rng 
Bleed 1 21 . 9 mg 17 't 0.5 14 
Bleed 2 23. 7 mg 17 . 5 '1: 0 . 7 14 
Bl eed 3 23.3 mg 79.1 -r i .5 66 
Alcohol prec i pitate from supernatant of antibody precipitati ons : 
11/eight Counts/minute Counts/minute/10 mg 
Bleed 1 28 . 3 mg 143 T 3.5 117 
Bleed 2 19 . 3 mg 113 -t 3 . 0 99 
Bleed 3 21 . 6 mg 91 t' 3 . 0 77 
Errors given are all nine-tenths statistical error 
-93-
TABLE V 
Rabbit 361 - Immunized Against Bovine Albumin and 
In jected with c14-Labeled Leucine 
0 1 2 3 4 5 
27 ml 
24 ml 
Time in days 
Injection of 
cl!J. leucine 
(1% soluti on) 20 ml 
Injection of 
rabbit antibody 
(anti-RBG ) 
20 ml 
20 ml 
6 13 20 27 
Bled 40 ml 40 ml 30 ml 
65 ml 30 ml 
Anti-bovine 
albumin (active 
antibody ) 
Anti-RBG 
(passive 
antibody) 
Fibrin 
Red cell 
Protein 
Alcohol ppt. 
from suptnt. 
Radioactivity Found 
Counts per min. per 10 mg 
36 40 21 
2.1 1.5 
16 
56 50 17 9 5.5 
13 8 33 28 25 
69 63 34 22 13 
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TABLE VI 
Radioactivity of Antibody Proteins from Rabbit 361, Immunized 
Against Bovine Serum Albumin and Injected with 
cl4-Labeled Leucine 
Bleed 1 
Bleed 2 
Bleed 3 
Bleed 4 
Bleed 5 
Bleed 1 
Bleed 2 
Active antibody - Anti-bovine albumin 
Precipitate 
Weight Counts/minute 
9 . 5 mg 29.0 ~ 1 . 4 
10.8 mg 34. 5 r 1.4 
6.7 mg 13.3 ~ 1 . 0 
1 . 1 mg 1.8 % 0. 4 
no antibody 
Passive antibody - Anti-RBG 
Precipitate 
Weight Counts/minute 
18.0 mg 2 . 8 :t 1 . 5 
2 . 2 z 1.0 
9 -4 mg 3. 8 't 1 .0 
Counts/min./10 mg 
36 
40 
21 
16 t 5 
Counts/min. /10 mg 
2 
5 
Bleed 3,4,5, no antibody 
Bleed 1 
Bleed 2 
Bleed 2 
Recounts 
10 . 8 mg 
6 . 2 mg 
l . h 1: 1 . 0 2. 2 %" 0 . 6 
0.9 T 1 . 2 
repeated with fresh material 
9 . 6 mg 
Errors given are all nine-tenths statistical error 
3 
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TABLE VII 
Rabbit 361 
La beled leucine 
Rabbit antibody 
Antibody Concentrations 
Bleed 1 Anti-bovine albumin 
Anti-ROO 
Bleed 2 Anti-bovine albumin 
Anti-RBG 
Bleed 3 Anti -bovine albumin 
Anti - RBG 
Bleed 4 Anti-bovi ne albumin 
Anti-RBG 
Bleed 5 No antibody 
Injected Material 
71 ml of a 1% solution. 
Acti vity of leucine was 7800 
counts per minute per mg in 
the counter used 
40 ml of solution. Solution 
gave 10. 9 mg of preci pitate 
per ml when titrated with RBG 
in Serum Samples 
3.8 mg of preci pitate per ml 
1. 8 mg of prec i pitate per ml 
1. 8 mg of precipitate per ml 
1.0 mg of prec i pita t e per ml 
2.1 mg of precipitate per ml 
negative 
1.6 mg of precipitate per ml 
negative 
. . . 
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TABLE VIII 
Radioactivity in Blood Proteins of Rabbit 361 
Fibrin : 
Weight Counts/minute Counts/min./10 mg 
Bleed 1 17.7 mg 61.5 t 1.0 56 
Bleed 2 21.7 mg 59.5 t' 1.2 50 
Bleed 3 2~.9 rng 20.4 "t 0.9 17 
Bleed 4 20.4 rng 10.3 r 0.7 9 
Bleed .5 20 • .5 rng 6.4 i' 0.6 5.5 
Red cell protein: 
Weight Counts/minute Counts/min./10 mg 
Bleed 1 16.3 rng 13.6 :t 0.6 13 
Bleed 2 18.6 mg 8.8 '!' 0.6 8 
Bleed 3 18.0 mg 36.9 "!' 1.0 33 
Bleed 4 15.7 mg 30.2 '!' 1.0 28 
Bleed 5 22.4 mg 29.8 t 1.0 2.5 
Alcohol precipitate from supernatant of antibody precipitati ons: 
Weight Counts/minute Counts/min./10 mg 
Bleed 1 28 .0 mg 84.9 '!' 1.3 69 
Bleed 2 29.4 mg 77.1 'i" 1.3 63 
Bleed 3 13.2 mg 32.8 't 1.0 34 
Bleed 4 12 • .5 mg 20.6 r o.6 22 
Bleed 5 19.5 mg 14.5 * 0.4 13 
Errors given are all nine-tenths statistical error 
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Prop·osi tions 
1. I t is proposed that it is not valid to draw conclusions 
about the fate of protein antigens f rom the experiments 
with rl31 labeled materials (l) {2). Further evidence is 
required that the fate of the r 131 also repres ents the fate 
of the antigen. This evidence could be obtained with pro-
tein material that contains cl4 in the norma l polypeptide 
chain a nd has a lso been iodinated with rl31. 
(1) F . Haurowitz, c. F . Crampton, and R. Sowinski, 
Federation Proceedi ngs, 10, 560 (1951) 
(2) F . J. Di xon, s. c. Bukantz, G. J. Dammin, and 
D. w. Talmag e , Federation Proceedings, 10, 553 (1951) 
2. A quantitative examination of the prec i pitin reaction 
in a protein-anti protein system should be carried out with 
immune serum from animals receiving cl4-labeled amino acids. 
It would be relatively easy to determine antigen-ant ibody 
ratios and the influence of numerous factors upon the reaction. 
J. Complement f r om guinea pigs receiving a labeled amino 
acid should be us ed i n a reinvestigation of the fixation of 
complement. By mixing different components of labeled and 
non-labeled complement the relative amounts of eac h com-
ponent may be obtained. 
4. A number of workers have studied the incorporation of 
labeled amino acids into proteins in the in vitro synthesis 
of protei n by surviving tissue. It has been proposed that 
some of these amino acids are not incorporated by the 
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formation of peptide bonds (3 ). The dif ficulty encountered 
in removing radioactivity from passive antibody precipitates 
(Part II of this thesis) would tend to support this. The 
nature of the combination mig ht be investigated by equilibrium 
dialysis studies. 
(3) A. Keaton and J. C. Dreyfus, Federation Proceeding s, 
10, 206 (1951 ) 
5. Equilibrium dialysis of labeled simple substances might 
be used to estimate t he valence of antibodies t o simple 
substances and the ~F of combination of simple substanc e 
and antibody. Some of t he difficulties , such as polymeri-
zation of dye haptens, encountered in the reported work (4) 
(5 ) could be avoided . 
(4) L. Lerman, Ph. D. Thesis, California Institute of 
Technology, (1949) 
(5 ) H. N. Ei s en and F . Karush, J. A. c. s ., 71 , 363 (1949 ) 
6. ·The explanation offered for t he solubility of horse 
ant itoxin - toxin precipitates in excess antitoxin (6) does 
not s eem r eas onable. The explanation is bas ed on the effect 
of hydrophilic groups on the antibody molecules . The in-
fluence of solubility of antibody might be investigated by 
coupling charg ed and uncharg ed groups of simila r s t ructures 
onto the antibody molecules. 
(6) W. C. Boyd, J . Exptl. Med., 74, 369 (1941 ) 
7. I t is propo s ed t ha t the adsorption iso therms of formal-
dehyde on dri ed proteins should be obtained . I t would be of 
interest to carry out t hese measurements with diphtheria t oxins 
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of varying toxicities to see if any relation could be estab-
lished with the detoxification by formalin. 
8 . There do not appear to be any data in the literature on 
the relative oxidation potentials of the sulfoxides . It is 
proposed that they be investigated as possible agents for 
the Oppenhauer oxidation (7). It may be that they would 
extend the range of oxidation potentials available. 
( 7 ) c. Djerassi, "Organic Reactions", 6, 207 (1951) 
9. It has been proposed that the equilibrium 
2 RMgX ~ R2Mg + MgX2 
exists in Grignar d s olutions and attempts to measure the 
equilibrium constant have been made by preci pitation of the 
RMgX and MgX2 with dioxane ( 8 ). The validity of this 
procedure has been questi oned because the rate of the re-
action is unknown (9) (10). It is proposed t hat the addition 
·of labeled R2Mg before the dioxane treatment could be used 
to determine if the conclusions from the dioxane studies are 
· valid. 
(8 ) A. C. Cope, J. A. C. S., 60, 2215 (1938) 
( 9 ) c. R. Noller and D. c. Raney, J. A. c. s., 62, 1749 
(1940) 
{10) G. H. Coleman and R. F . Blomquist, J. A. c. s. 63, 
1692 (1941) 
10. I t is proposed that some of the reported discontinuities 
in adsorption isotherms are not real. In particular discon-
tinuities in the adsorption isotherms of carbon dioxide on 
charcoal have been reported but there appears to be some 
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discrepancy between the two me t hods of obtaining the data 
(11). I t is proposed that these i sotherms s hould be ob-
tained by using an apparatus containing a modi fied McLeod 
gauge (12). A variable volume apparatus could also be used. 
(11) L. J. Burrage, J. Phys. Chern., 36, 2272 (1932) 
(12) H. o. McMahon and M. J. Marshall, Trans. El ec t ro-
chemical Soc., 84, 109 (1943) 
11. I t is proposed that a more satisfactory method for 
the determ~nation of density gradients in sea water is 
needed. I t may be possible to obtain these gradients from 
the corresponding variation in the velocity of sound. The 
necessary measurement s mi ght be made with a n ultrasonic 
interferometer ( 13) •. 
(13) E. A. Neumann, Proc. Phys. Soc. Lond., 59, 585 
(1947) 
